<?xml version="1.0" encoding="UTF-8"?><!-- Normalized for easier text mining. --><xocs:doc xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.elsevier.com/xml/ja/dtd" xmlns:ja="http://www.elsevier.com/xml/ja/dtd" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:tb="http://www.elsevier.com/xml/common/table/dtd" xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:cals="http://www.elsevier.com/xml/common/cals/dtd" xsi:schemaLocation="http://www.elsevier.com/xml/xocs/dtd http://schema.elsevier.com/dtds/document/fulltext/xcr/xocs-article.xsd"><xocs:meta><xocs:content-family>serial</xocs:content-family><xocs:content-type>JL</xocs:content-type><xocs:cid>280959</xocs:cid><xocs:srctitle>Cell Reports</xocs:srctitle><xocs:normalized-srctitle>CELLREPORTS</xocs:normalized-srctitle><xocs:orig-load-date>2013-11-27</xocs:orig-load-date><xocs:ew-transaction-id>2013-12-07T01:41:33</xocs:ew-transaction-id><xocs:eid>1-s2.0-S2211124713006475</xocs:eid><xocs:pii-formatted>S2211-1247(13)00647-5</xocs:pii-formatted><xocs:pii-unformatted>S2211124713006475</xocs:pii-unformatted><xocs:doi>10.1016/j.celrep.2013.10.048</xocs:doi><xocs:item-stage>S300</xocs:item-stage><xocs:item-version-number>S300.1</xocs:item-version-number><xocs:item-weight>FULL-TEXT</xocs:item-weight><xocs:hub-eid>1-s2.0-S2211124713X0018X</xocs:hub-eid><xocs:timestamp>2014-02-03T15:49:17.375994-05:00</xocs:timestamp><xocs:issns><xocs:issn-primary-formatted>2211-1247</xocs:issn-primary-formatted><xocs:issn-primary-unformatted>22111247</xocs:issn-primary-unformatted></xocs:issns><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NIH</xocs:funding-body-id><xocs:crossmark>true</xocs:crossmark><xocs:vol-first>5</xocs:vol-first><xocs:iss-first>5</xocs:iss-first><xocs:vol-iss-suppl-text>Volume 5, Issue 5</xocs:vol-iss-suppl-text><xocs:sort-order>21</xocs:sort-order><xocs:first-fp>1387</xocs:first-fp><xocs:last-lp>1402</xocs:last-lp><xocs:pages><xocs:first-page>1387</xocs:first-page><xocs:last-page>1402</xocs:last-page></xocs:pages><xocs:cover-date-orig><xocs:start-date>20131212</xocs:start-date></xocs:cover-date-orig><xocs:cover-date-text>12 December 2013</xocs:cover-date-text><xocs:cover-date-start>2013-12-12</xocs:cover-date-start><xocs:cover-date-year>2013</xocs:cover-date-year><xocs:hub-sec><xocs:hub-sec-title>Articles</xocs:hub-sec-title></xocs:hub-sec><xocs:document-type>article</xocs:document-type><xocs:document-subtype>fla</xocs:document-subtype><xocs:copyright-line>Copyright Â© 2013 The Authors. Published by Elsevier Inc. All rights reserved.</xocs:copyright-line><xocs:normalized-article-title>SPECIFICATIONFUNCTIONALCRANIALPLACODEDERIVATIVESHUMANPLURIPOTENTSTEMCELLS</xocs:normalized-article-title><xocs:normalized-first-auth-surname>DINCER</xocs:normalized-first-auth-surname><xocs:normalized-first-auth-initial>Z</xocs:normalized-first-auth-initial><xocs:item-toc><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Introduction</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Results</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Derepression of Endogenous BMP Signaling Induces Placode at the Expense of Neuroectoderm</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Microarray Analysis Reveals Human Placode Progenitor Gene Expression</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Early Treatment with FGF Inhibitor Suppresses Placode and Induces Surface Ectoderm Fate</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Placode Precursors Efficiently Differentiate into Trigeminal-type Sensory Neurons</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>In Vivo Analysis of hESC-Derived Trigeminal Neurons in the Developing Chick Embryo and Adult Mouse CNS</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Identification of a Putative Preplacode Stage</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Treatment with FGF Inhibitor SU5402 at Preplacode Stage Induces Lens Fates</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Treatment with SHH at Preplacode Stage Induces Anterior Pituitary Cells</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Discussion</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>An Experimental Platform for the Efficient Generation of Human Cranial Placodes In Vitro</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Specification toward Functional hESC-Derived Placode Derivatives</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Experimental Procedures</xocs:item-toc-section-title><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Cell Culture</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Cell Characterization</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Animal Studies</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:sections"><xocs:item-toc-section-title>Statistical Analysis</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:acknowledgment"><xocs:item-toc-section-title>Acknowledgments</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:appendices"><xocs:item-toc-section-title>Accession Numbers</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:appendices"><xocs:item-toc-section-title>Supplemental Information</xocs:item-toc-section-title></xocs:item-toc-entry><xocs:item-toc-entry ref-elem="ce:bibliography"><xocs:item-toc-section-title>References</xocs:item-toc-section-title></xocs:item-toc-entry></xocs:item-toc><xocs:references><xocs:ref-info refid="sref1"><xocs:ref-normalized-surname>ABDELHAK</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>157</xocs:ref-first-fp><xocs:ref-last-lp>164</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref2"><xocs:ref-normalized-surname>AHRENS</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>40</xocs:ref-first-fp><xocs:ref-last-lp>59</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref3"><xocs:ref-normalized-surname>ARKELL</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>1</xocs:ref-first-fp><xocs:ref-last-lp>12</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref4"><xocs:ref-normalized-surname>BAILEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>505</xocs:ref-first-fp><xocs:ref-last-lp>517</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref5"><xocs:ref-normalized-surname>BAKER</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>1</xocs:ref-first-fp><xocs:ref-last-lp>61</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref6"><xocs:ref-normalized-surname>BALMER</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>464</xocs:ref-first-fp><xocs:ref-last-lp>481</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref7"><xocs:ref-normalized-surname>BARNETT</xocs:ref-normalized-surname><xocs:ref-pub-year>1994</xocs:ref-pub-year><xocs:ref-first-fp>782</xocs:ref-first-fp><xocs:ref-last-lp>786</xocs:ref-last-lp><xocs:ref-normalized-initial>E</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref8"><xocs:ref-normalized-surname>BERNARDO</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>144</xocs:ref-first-fp><xocs:ref-last-lp>155</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref9"><xocs:ref-normalized-surname>BHATTACHARYYA</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>520</xocs:ref-first-fp><xocs:ref-last-lp>526</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref10"><xocs:ref-normalized-surname>CHAMBERS</xocs:ref-normalized-surname><xocs:ref-pub-year>2009</xocs:ref-pub-year><xocs:ref-first-fp>275</xocs:ref-first-fp><xocs:ref-last-lp>280</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref11"><xocs:ref-normalized-surname>CHAMBERS</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>715</xocs:ref-first-fp><xocs:ref-last-lp>720</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref12"><xocs:ref-normalized-surname>CHEN</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>278</xocs:ref-first-fp><xocs:ref-last-lp>282</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref13"><xocs:ref-normalized-surname>COLAS</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>141</xocs:ref-first-fp><xocs:ref-last-lp>148</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref14"><xocs:ref-normalized-surname>DENNIS</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref15"><xocs:ref-normalized-surname>ELKABETZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>152</xocs:ref-first-fp><xocs:ref-last-lp>165</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref16"><xocs:ref-normalized-surname>GRIGALIUNAS</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>2058</xocs:ref-first-fp><xocs:ref-last-lp>2074</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref17"><xocs:ref-normalized-surname>GROTEWOLD</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>327</xocs:ref-first-fp><xocs:ref-last-lp>330</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref18"><xocs:ref-normalized-surname>HUNTER</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>67</xocs:ref-first-fp><xocs:ref-last-lp>77</xocs:ref-last-lp><xocs:ref-normalized-initial>C</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref19"><xocs:ref-normalized-surname>ISHIHARA</xocs:ref-normalized-surname><xocs:ref-pub-year>2008</xocs:ref-pub-year><xocs:ref-first-fp>3142</xocs:ref-first-fp><xocs:ref-last-lp>3156</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref20"><xocs:ref-normalized-surname>KOEHLER</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>217</xocs:ref-first-fp><xocs:ref-last-lp>221</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref21"><xocs:ref-normalized-surname>KUDOH</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>3581</xocs:ref-first-fp><xocs:ref-last-lp>3592</xocs:ref-last-lp><xocs:ref-normalized-initial>T</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref22"><xocs:ref-normalized-surname>KWON</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>e1001133</xocs:ref-first-fp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref23"><xocs:ref-normalized-surname>LAFAILLE</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>769</xocs:ref-first-fp><xocs:ref-last-lp>773</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref24"><xocs:ref-normalized-surname>LEE</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>1468</xocs:ref-first-fp><xocs:ref-last-lp>1475</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref25"><xocs:ref-normalized-surname>LEUNG</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>208</xocs:ref-first-fp><xocs:ref-last-lp>220</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref26"><xocs:ref-normalized-surname>LITSIOU</xocs:ref-normalized-surname><xocs:ref-pub-year>2005</xocs:ref-pub-year><xocs:ref-first-fp>4051</xocs:ref-first-fp><xocs:ref-last-lp>4062</xocs:ref-last-lp><xocs:ref-normalized-initial>A</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref27"><xocs:ref-normalized-surname>LOVE</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>2347</xocs:ref-first-fp><xocs:ref-last-lp>2360</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref28"><xocs:ref-normalized-surname>MACKAY</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>38</xocs:ref-first-fp><xocs:ref-last-lp>52</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref29"><xocs:ref-normalized-surname>MARTIN</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>877</xocs:ref-first-fp><xocs:ref-last-lp>887</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref30"><xocs:ref-normalized-surname>MCCABE</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>462</xocs:ref-first-fp><xocs:ref-last-lp>477</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref31"><xocs:ref-normalized-surname>MCCAULEY</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>129</xocs:ref-first-fp><xocs:ref-last-lp>139</xocs:ref-last-lp><xocs:ref-normalized-initial>D</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref32"><xocs:ref-normalized-surname>MENENDEZ</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>19240</xocs:ref-first-fp><xocs:ref-last-lp>19245</xocs:ref-last-lp><xocs:ref-normalized-initial>L</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref33"><xocs:ref-normalized-surname>MENGARELLI</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>94</xocs:ref-first-fp><xocs:ref-last-lp>106</xocs:ref-last-lp><xocs:ref-normalized-initial>I</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref34"><xocs:ref-normalized-surname>METCALFE</xocs:ref-normalized-surname><xocs:ref-pub-year>1990</xocs:ref-pub-year><xocs:ref-first-fp>491</xocs:ref-first-fp><xocs:ref-last-lp>504</xocs:ref-last-lp><xocs:ref-normalized-initial>W</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref35"><xocs:ref-normalized-surname>MICA</xocs:ref-normalized-surname><xocs:ref-pub-year>2013</xocs:ref-pub-year><xocs:ref-first-fp>1140</xocs:ref-first-fp><xocs:ref-last-lp>1152</xocs:ref-last-lp><xocs:ref-normalized-initial>Y</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref36"><xocs:ref-normalized-surname>ORAHILLY</xocs:ref-normalized-surname><xocs:ref-pub-year>1987</xocs:ref-pub-year><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial><xocs:ref-normalized-srctitle>DEVELOPMENTALSTAGESINHUMANEMBRYOS</xocs:ref-normalized-srctitle></xocs:ref-info><xocs:ref-info refid="sref37"><xocs:ref-normalized-surname>OOTO</xocs:ref-normalized-surname><xocs:ref-pub-year>2003</xocs:ref-pub-year><xocs:ref-first-fp>2689</xocs:ref-first-fp><xocs:ref-last-lp>2693</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref38"><xocs:ref-normalized-surname>OSHIMA</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>704</xocs:ref-first-fp><xocs:ref-last-lp>716</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref39"><xocs:ref-normalized-surname>PIEPER</xocs:ref-normalized-surname><xocs:ref-pub-year>2012</xocs:ref-pub-year><xocs:ref-first-fp>1175</xocs:ref-first-fp><xocs:ref-last-lp>1187</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref40"><xocs:ref-normalized-surname>REUBINOFF</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>1134</xocs:ref-first-fp><xocs:ref-last-lp>1140</xocs:ref-last-lp><xocs:ref-normalized-initial>B</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref41"><xocs:ref-normalized-surname>RUF</xocs:ref-normalized-surname><xocs:ref-pub-year>2004</xocs:ref-pub-year><xocs:ref-first-fp>8090</xocs:ref-first-fp><xocs:ref-last-lp>8095</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref42"><xocs:ref-normalized-surname>SASAKI</xocs:ref-normalized-surname><xocs:ref-pub-year>1993</xocs:ref-pub-year><xocs:ref-first-fp>47</xocs:ref-first-fp><xocs:ref-last-lp>59</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref43"><xocs:ref-normalized-surname>SCHLOSSER</xocs:ref-normalized-surname><xocs:ref-pub-year>2006</xocs:ref-pub-year><xocs:ref-first-fp>303</xocs:ref-first-fp><xocs:ref-last-lp>351</xocs:ref-last-lp><xocs:ref-normalized-initial>G</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref44"><xocs:ref-normalized-surname>SCULLY</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>2231</xocs:ref-first-fp><xocs:ref-last-lp>2235</xocs:ref-last-lp><xocs:ref-normalized-initial>K</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref45"><xocs:ref-normalized-surname>SHI</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>3016</xocs:ref-first-fp><xocs:ref-last-lp>3023</xocs:ref-last-lp><xocs:ref-normalized-initial>F</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref46"><xocs:ref-normalized-surname>SJODAL</xocs:ref-normalized-surname><xocs:ref-pub-year>2007</xocs:ref-pub-year><xocs:ref-first-fp>141</xocs:ref-first-fp><xocs:ref-last-lp>149</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref47"><xocs:ref-normalized-surname>STARK</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>4287</xocs:ref-first-fp><xocs:ref-last-lp>4295</xocs:ref-last-lp><xocs:ref-normalized-initial>M</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref48"><xocs:ref-normalized-surname>SUGA</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>57</xocs:ref-first-fp><xocs:ref-last-lp>62</xocs:ref-last-lp><xocs:ref-normalized-initial>H</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref49"><xocs:ref-normalized-surname>TABAR</xocs:ref-normalized-surname><xocs:ref-pub-year>2011</xocs:ref-pub-year><xocs:ref-first-fp>490</xocs:ref-first-fp><xocs:ref-last-lp>491</xocs:ref-last-lp><xocs:ref-normalized-initial>V</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref50"><xocs:ref-normalized-surname>TREMBLAY</xocs:ref-normalized-surname><xocs:ref-pub-year>1998</xocs:ref-pub-year><xocs:ref-first-fp>428</xocs:ref-first-fp><xocs:ref-last-lp>441</xocs:ref-last-lp><xocs:ref-normalized-initial>J</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref51"><xocs:ref-normalized-surname>WILSON</xocs:ref-normalized-surname><xocs:ref-pub-year>1997</xocs:ref-pub-year><xocs:ref-first-fp>3177</xocs:ref-first-fp><xocs:ref-last-lp>3184</xocs:ref-last-lp><xocs:ref-normalized-initial>P</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref52"><xocs:ref-normalized-surname>XU</xocs:ref-normalized-surname><xocs:ref-pub-year>2002</xocs:ref-pub-year><xocs:ref-first-fp>1261</xocs:ref-first-fp><xocs:ref-last-lp>1264</xocs:ref-last-lp><xocs:ref-normalized-initial>R</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref53"><xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2001</xocs:ref-pub-year><xocs:ref-first-fp>1129</xocs:ref-first-fp><xocs:ref-last-lp>1133</xocs:ref-last-lp><xocs:ref-normalized-initial>S</xocs:ref-normalized-initial></xocs:ref-info><xocs:ref-info refid="sref54"><xocs:ref-normalized-surname>ZHANG</xocs:ref-normalized-surname><xocs:ref-pub-year>2010</xocs:ref-pub-year><xocs:ref-first-fp>90</xocs:ref-first-fp><xocs:ref-last-lp>100</xocs:ref-last-lp><xocs:ref-normalized-initial>X</xocs:ref-normalized-initial></xocs:ref-info></xocs:references><xocs:attachment-metadata-doc><xocs:attachment-set-type>item</xocs:attachment-set-type><xocs:pii-formatted>S2211-1247(13)00647-5</xocs:pii-formatted><xocs:pii-unformatted>S2211124713006475</xocs:pii-unformatted><xocs:eid>1-s2.0-S2211124713006475</xocs:eid><xocs:doi>10.1016/j.celrep.2013.10.048</xocs:doi><xocs:cid>280959</xocs:cid><xocs:timestamp>2013-12-12T10:00:32.711417-05:00</xocs:timestamp><xocs:path>/280959/1-s2.0-S2211124713X0018X/1-s2.0-S2211124713006475/</xocs:path><xocs:cover-date-start>2013-12-12</xocs:cover-date-start><xocs:sponsored-access-type>UNLIMITED</xocs:sponsored-access-type><xocs:funding-body-id>NIH</xocs:funding-body-id><xocs:attachments><xocs:web-pdf><xocs:attachment-eid>1-s2.0-S2211124713006475-main.pdf</xocs:attachment-eid><xocs:filename>main.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:pdf-optimized>true</xocs:pdf-optimized><xocs:filesize>6396101</xocs:filesize><xocs:web-pdf-purpose>MAIN</xocs:web-pdf-purpose><xocs:web-pdf-page-count>16</xocs:web-pdf-page-count><xocs:web-pdf-images><xocs:web-pdf-image><xocs:attachment-eid>1-s2.0-S2211124713006475-main_1.png</xocs:attachment-eid><xocs:filename>main_1.png</xocs:filename><xocs:extension>png</xocs:extension><xocs:filesize>128528</xocs:filesize><xocs:pixel-height>849</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-WEB-PDF</xocs:attachment-type><xocs:pdf-page-num>1</xocs:pdf-page-num></xocs:web-pdf-image></xocs:web-pdf-images></xocs:web-pdf><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-mmc2.xlsx</xocs:attachment-eid><xocs:file-basename>mmc2</xocs:file-basename><xocs:filename>mmc2.xlsx</xocs:filename><xocs:extension>xlsx</xocs:extension><xocs:filesize>56682</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr3.jpg</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>118015</xocs:filesize><xocs:pixel-height>640</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr4.jpg</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>219634</xocs:filesize><xocs:pixel-height>971</xocs:pixel-height><xocs:pixel-width>710</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-fx1.jpg</xocs:attachment-eid><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>43541</xocs:filesize><xocs:pixel-height>375</xocs:pixel-height><xocs:pixel-width>375</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr7.jpg</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>55692</xocs:filesize><xocs:pixel-height>334</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr2.jpg</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>166463</xocs:filesize><xocs:pixel-height>788</xocs:pixel-height><xocs:pixel-width>769</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr6.jpg</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>184039</xocs:filesize><xocs:pixel-height>952</xocs:pixel-height><xocs:pixel-width>762</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr1.jpg</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>174988</xocs:filesize><xocs:pixel-height>871</xocs:pixel-height><xocs:pixel-width>656</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr5.jpg</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.jpg</xocs:filename><xocs:extension>jpg</xocs:extension><xocs:filesize>186831</xocs:filesize><xocs:pixel-height>962</xocs:pixel-height><xocs:pixel-width>760</xocs:pixel-width><xocs:attachment-type>IMAGE-DOWNSAMPLED</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr3.sml</xocs:attachment-eid><xocs:file-basename>gr3</xocs:file-basename><xocs:filename>gr3.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8745</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>197</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr4.sml</xocs:attachment-eid><xocs:file-basename>gr4</xocs:file-basename><xocs:filename>gr4.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8773</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>120</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-fx1.sml</xocs:attachment-eid><xocs:file-basename>fx1</xocs:file-basename><xocs:abstract-attachment>true</xocs:abstract-attachment><xocs:filename>fx1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>10197</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>164</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr7.sml</xocs:attachment-eid><xocs:file-basename>gr7</xocs:file-basename><xocs:filename>gr7.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>5434</xocs:filesize><xocs:pixel-height>111</xocs:pixel-height><xocs:pixel-width>219</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr2.sml</xocs:attachment-eid><xocs:file-basename>gr2</xocs:file-basename><xocs:filename>gr2.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>9182</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>160</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr6.sml</xocs:attachment-eid><xocs:file-basename>gr6</xocs:file-basename><xocs:filename>gr6.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8374</xocs:filesize><xocs:pixel-height>164</xocs:pixel-height><xocs:pixel-width>131</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr1.sml</xocs:attachment-eid><xocs:file-basename>gr1</xocs:file-basename><xocs:filename>gr1.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8552</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>123</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-gr5.sml</xocs:attachment-eid><xocs:file-basename>gr5</xocs:file-basename><xocs:filename>gr5.sml</xocs:filename><xocs:extension>sml</xocs:extension><xocs:filesize>8687</xocs:filesize><xocs:pixel-height>163</xocs:pixel-height><xocs:pixel-width>129</xocs:pixel-width><xocs:attachment-type>IMAGE-THUMBNAIL</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-mmc4.pdf</xocs:attachment-eid><xocs:file-basename>mmc4</xocs:file-basename><xocs:filename>mmc4.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>8373820</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-mmc1.pdf</xocs:attachment-eid><xocs:file-basename>mmc1</xocs:file-basename><xocs:filename>mmc1.pdf</xocs:filename><xocs:extension>pdf</xocs:extension><xocs:filesize>1984881</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment><xocs:attachment><xocs:attachment-eid>1-s2.0-S2211124713006475-mmc3.xls</xocs:attachment-eid><xocs:file-basename>mmc3</xocs:file-basename><xocs:filename>mmc3.xls</xocs:filename><xocs:extension>xls</xocs:extension><xocs:filesize>120320</xocs:filesize><xocs:attachment-type>APPLICATION</xocs:attachment-type></xocs:attachment></xocs:attachments></xocs:attachment-metadata-doc><xocs:refkeys><xocs:refkey3>DINCERX2013X1387</xocs:refkey3><xocs:refkey4lp>DINCERX2013X1387X1402</xocs:refkey4lp><xocs:refkey4ai>DINCERX2013X1387XZ</xocs:refkey4ai><xocs:refkey5>DINCERX2013X1387X1402XZ</xocs:refkey5></xocs:refkeys><xocs:open-access><xocs:oa-article-status is-open-access="1" is-open-archive="0">Full</xocs:oa-article-status><xocs:oa-access-effective-date>2013-10-31T19:00:56Z</xocs:oa-access-effective-date><xocs:oa-sponsor><xocs:oa-sponsor-type>ElsevierWaived</xocs:oa-sponsor-type></xocs:oa-sponsor><xocs:oa-user-license>http://creativecommons.org/licenses/by/3.0/</xocs:oa-user-license></xocs:open-access></xocs:meta><xocs:serial-item><article xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/dtd" docsubtype="fla" version="5.2" xml:lang="en"><item-info><jid>CELREP</jid><aid>703</aid><ce:pii>S2211-1247(13)00647-5</ce:pii><ce:doi>10.1016/j.celrep.2013.10.048</ce:doi><ce:copyright type="other" year="2013">The Authors</ce:copyright></item-info><ce:floats><ce:figure id="fig1"><ce:label>Figure 1</ce:label><ce:caption id="cap0010"><ce:simple-para id="fspara0010" view="all">Derivation of Six1<ce:sup loc="post">+</ce:sup> Placodal Precursors Using a Modified Dual-SMAD Inhibition Protocol</ce:simple-para><ce:simple-para id="fspara0015" view="all">(A) Schematic illustration of timed Noggin withdrawal paradigm to determine temporal requirement for endogenous BMP signaling during placode specification. The protocol is based on modifying the (N)oggin + (S)B431542 (NSB) protocol developed for CNS induction (<ce:cross-ref refid="bib10" id="crosref0895">Chambers et al., 2009</ce:cross-ref>).</ce:simple-para><ce:simple-para id="fspara0020" view="all">(B) Relative induction of placodal markers comparing modified NSB protocol (various time points of Noggin withdrawal) to N-SB treatment maintained throughout differentiation (NSB condition). Data represent fold changes of mRNA expression measured by qRT-PCR at day 11.</ce:simple-para><ce:simple-para id="fspara0025" view="all">(C) Immunocytochemical analyses of SIX1 and PAX6 expression at day 11 of differentiation. Inset shows a confocal section to demonstrate SIX1 expression within clusters. Scale bars correspond to 50 Î¼m.</ce:simple-para><ce:simple-para id="fspara0030" view="all">(D) Quantification of the percentage of Six1<ce:sup loc="post">+</ce:sup> cells generated under modified N-SB (SB3 = placode induction (PIP) protocol) versus N-SB condition.</ce:simple-para><ce:simple-para id="fspara0035" view="all">(E) Immunocytochemical analysis of placodal markers EYA1, DACH1, and FOXG1 in placodal clusters. Insets show higher magnification images for respective marker. Scale bars correspond to 50 Î¼m.</ce:simple-para><ce:simple-para id="fspara0040" view="all">(F-H) Temporal analysis of gene expression in PIP versus N-SB protocol. Values are normalized to the expression observed in undifferentiated hESCs. (F) Loss of expression of pluripotency (<ce:italic>NANOG</ce:italic>, <ce:italic>OCT4/POU5F1</ce:italic>) and trophectodermal (TE) markers. (G) Lack of expression of mesodermal and endodermal markers. (H) Induction of placodal fates by monitoring time-course expression of pluripotency markers (<ce:italic>NANOG</ce:italic>, <ce:italic>OCT4</ce:italic>), trophectoderm (<ce:italic>CDX2</ce:italic>), mesoderm (<ce:italic>T</ce:italic>), endoderm (<ce:italic>SOX17</ce:italic>), and placodal markers (<ce:italic>DLX3</ce:italic>, <ce:italic>SIX1</ce:italic>, <ce:italic>FOXG1</ce:italic>).</ce:simple-para><ce:simple-para id="fspara0045" view="all">Error bar represents SD <ce:sup loc="pre">â</ce:sup>p &lt; 0.05; <ce:sup loc="pre">ââ</ce:sup>p &lt; 0.01; <ce:sup loc="pre">âââ</ce:sup>p &lt; 0.001 compared with control N-SB condition (n = 3 independent experiments). See also <ce:cross-ref refid="app3" id="crosref0900">Figure S1</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr1"/></ce:figure><ce:figure id="fig2"><ce:label>Figure 2</ce:label><ce:caption id="cap0015"><ce:simple-para id="fspara0050" view="all">Temporal Global Gene Expression Profiles during hESC-Derived Placode Specification</ce:simple-para><ce:simple-para id="fspara0055" view="all">(A) Clustering of the differentially regulated genes during PIP versus N-SB protocol.</ce:simple-para><ce:simple-para id="fspara0060" view="all">(B-E) The top 20 most significant up- (red) and downregulated (blue) genes in PIP versus N-SB protocol by fold change at days 5, 7, 9, and 11.</ce:simple-para><ce:simple-para id="fspara0065" view="all">(F and G) Confirmation of ISL1 and TFAP2A expression at the protein level under PIP conditions (day 11).</ce:simple-para><ce:simple-para id="fspara0070" view="all">(H) Confirmation of OVOL2 expression by immunocytochemistry (day 11).</ce:simple-para><ce:simple-para id="fspara0075" view="all">(I) Time-course analysis of <ce:italic>OVOL2</ce:italic> gene expression during PIP, N-SB, and NC protocol.</ce:simple-para><ce:simple-para id="fspara0080" view="all">Scale bars in (F)-(H) correspond to 50 Î¼m. See also <ce:cross-ref refid="app3" id="crosref0905">Figure S2</ce:cross-ref> and <ce:cross-ref refid="app3" id="crosref0910">Tables S1</ce:cross-ref> and <ce:cross-ref refid="app3" id="crosref0915">S2</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr2"/></ce:figure><ce:figure id="fig3"><ce:label>Figure 3</ce:label><ce:caption id="cap0020"><ce:simple-para id="fspara0085" view="all">FGF Signaling Determines Placodal versus Nonneural Ectoderm/Epidermal Fate</ce:simple-para><ce:simple-para id="fspara0090" view="all">(A and B) Time course of the induction of <ce:italic>TFAP2A</ce:italic> and <ce:italic>SIX1</ce:italic> under PIP conditions.</ce:simple-para><ce:simple-para id="fspara0095" view="all">(C) TFAP2A (green) is expressed in placodes and surface ectoderm, whereas SIX1 (red) is only expressed in placode cells. Blocking PIP via pharmacological inhibition of endogenous FGF signaling blocks the formation of SIX1<ce:sup loc="post">+</ce:sup> cells.</ce:simple-para><ce:simple-para id="fspara0100" view="all">(D) Quantification of the loss of <ce:italic>SIX1</ce:italic> gene expression following treatment with the FGF inhibitor SU5402.</ce:simple-para><ce:simple-para id="fspara0105" view="all">(E) Expression of early epidermal marker <ce:italic>KRT8</ce:italic>. Data represent fold changes of mRNA expression by qRT-PCR at day 11 compared to PIP condition.</ce:simple-para><ce:simple-para id="fspara0110" view="all">(F) Expression of late epidermal marker <ce:italic>KRT14</ce:italic> during keratinocyte differentiation. Data represent fold changes of mRNA expression by qRT-PCR at day 11 and day 42 compared to hESC.</ce:simple-para><ce:simple-para id="fspara0115" view="all">(G) Long-term SU5402-treated cultures are expressing KRT 14 protein suggesting epidermal/keratinocyte fate.</ce:simple-para><ce:simple-para id="fspara0120" view="all">Error bar represents SD <ce:sup loc="pre">â</ce:sup>p &lt; 0.05; <ce:sup loc="pre">ââ</ce:sup>p &lt; 0.01; <ce:sup loc="pre">âââ</ce:sup>p &lt; 0.001 compared with control PIP condition (n = 3 independent experiments). Scale bars in (C) and (G) correspond to 50 Î¼m. See also <ce:cross-ref refid="app3" id="crosref0920">Figure S3</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr3"/></ce:figure><ce:figure id="fig4"><ce:label>Figure 4</ce:label><ce:caption id="cap0025"><ce:simple-para id="fspara0125" view="all">Derivation, Characterization, and Transplantation of hESC-Derived Trigeminal-type Sensory Neurons</ce:simple-para><ce:simple-para id="fspara0130" view="all">(A) Schematic representation of various placodes derived during development for preplacode cells including hormone-producing cells (pituitary placode), structural cells such as lens fibers (lens placode), and sensory neurons (trigeminal placode). Trigeminal placode fate (highlighted in orange) appears to be a default under PIP conditions.</ce:simple-para><ce:simple-para id="fspara0135" view="all">(B) PAX3, a trigeminal placode marker, is expressed in SIX1<ce:sup loc="post">+</ce:sup> placode clusters at the placode stage at day 11.</ce:simple-para><ce:simple-para id="fspara0140" view="all">(C) Placode clusters by default rapidly yield cells expressing sensory neuron makers such as ISL1 and HNK1.</ce:simple-para><ce:simple-para id="fspara0145" view="all">(D) Immunocytochemical analysis at day 20 of differentiation demonstrates that SIX1<ce:sup loc="post">+</ce:sup> placodal clusters efficiently yield large numbers of TUJ1-positive neurons that initially retain SIX1 expression.</ce:simple-para><ce:simple-para id="fspara0150" view="all">(E) Sensory neuron identity is further confirmed by expression of BRN3A in the majority of neurons derived from SIX1<ce:sup loc="post">+</ce:sup> clusters.</ce:simple-para><ce:simple-para id="fspara0155" view="all">(F) At day 42 of differentiation, neurons show increased expression of peripherin and decreased levels of TUJ1 staining suggesting adoption of a more mature peripheral neuron fate.</ce:simple-para><ce:simple-para id="fspara0160" view="all">(G) Trigeminal neurons stain for glutamate.</ce:simple-para><ce:simple-para id="fspara0165" view="all">(H-K) (H) Expression of <ce:italic>RUNX</ce:italic> factors, (I) <ce:italic>TRK</ce:italic> receptors, (J and K) nociceptor-specific channels and receptors in trigeminal neurons responsible for hot (TRPV1) and cold (TRPM8) sensation and for inflammatory pain (P2X3; n = 3 independent experiments; error bars represent SEM).</ce:simple-para><ce:simple-para id="fspara0170" view="all">(L and M) Examples of single cell patch clamp electrophysiological analysis in hESC-derived trigeminal-type neurons at day 53 of differentiation.</ce:simple-para><ce:simple-para id="fspara0175" view="all">(N) The intensity of the stimulus was started from -125 pA and increased by 25 pA until a single action potential was observed. Steps shown correspond to 25 pA increments.</ce:simple-para><ce:simple-para id="fspara0180" view="all">(O) Summary of quantitative electrophysiological parameters showed comparable patterns for both bipolar and tripolar type neurons.</ce:simple-para><ce:simple-para id="fspara0185" view="all">(P-S) Transplantation into trigeminal anlage in chick embryo. (P) GFP-labeled cells and graft morphology 2 days after transplantation. (Q) Low-power image shows GFP<ce:sup loc="post">+</ce:sup> fiber bundles: GFP (green) and DAPI (blue). Insert, section at midbrain level shows GFP<ce:sup loc="post">+</ce:sup> fiber bundles adjacent to trigeminal anlage. (R) The human fiber bundles express human cytoplasmic marker (green) and the sensory neuron marker, peripherin (red). (S) GFP<ce:sup loc="post">+</ce:sup>/PERIPHERIN<ce:sup loc="post">+</ce:sup> cells bodies are arranged in ganglia-like clusters in vivo.</ce:simple-para><ce:simple-para id="fspara0190" view="all">All scale bars correspond to 50 Î¼m. See also <ce:cross-ref refid="app3" id="crosref0925">Figures S4</ce:cross-ref> and <ce:cross-ref refid="app3" id="crosref0930">S5</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr4"/></ce:figure><ce:figure id="fig5"><ce:label>Figure 5</ce:label><ce:caption id="cap0030"><ce:simple-para id="fspara0195" view="all">Identification of Putative Preplacode and Directed Differentiation toward Human Lens Placode Lineage</ce:simple-para><ce:simple-para id="fspara0200" view="all">(A) Immunocytochemical analysis for TFAP2A and PAX6 at day 3 of differentiation.</ce:simple-para><ce:simple-para id="fspara0205" view="all">(B) Time-course analysis at days 5, 7, 9, and 11 of PIP differentiation show coexpression of TFAP2A and PAX6 at days 7 and 9 of differentiation.</ce:simple-para><ce:simple-para id="fspara0210" view="all">(C) Time-course analysis at days 5, 7, 9, and 11 of N-SB differentiation shows lack of TFAP2A expression but expression of PAX6 in CNS neuroectodermal cells.</ce:simple-para><ce:simple-para id="fspara0215" view="all">(D) Temporal analysis of <ce:italic>PAX3</ce:italic> gene expression during PIP versus NSB protocol.</ce:simple-para><ce:simple-para id="fspara0220" view="all">(E) <ce:italic>PAX3</ce:italic> expression levels following treatment (days 7-11) with activators or inhibitor of FGF (FGF8, SU5402) and WNT signaling (CHIR99021, XAV939) during PIP.</ce:simple-para><ce:simple-para id="fspara0225" view="all">(F) <ce:italic>PAX6</ce:italic> expression levels using same treatment as in (E).</ce:simple-para><ce:simple-para id="fspara1225" view="all">(G) Results of a four signaling pathway screen (modulators of BMP, FGF, WNT, and SHH signaling added at days 7-11 of PIP). Induction of the lens placode marker <ce:italic>PITX3</ce:italic> by qRT-PCR was observed upon treatment with activators of BMP signaling (BMP4) or inhibitors of FGF signaling (SU5402).</ce:simple-para><ce:simple-para id="fspara0230" view="all">(H) Modified placode cultures differentiating into Crystalline<ce:sup loc="post">+</ce:sup> cells with mature lens fiber morphologies by day 57 of differentiation.</ce:simple-para><ce:simple-para id="fspara0235" view="all">Scale bars in (A)-(C) correspond to 25 Î¼m. Scale bars in (H) correspond to 50 Î¼m. Error bar represents SD. <ce:sup loc="pre">â</ce:sup>p &lt; 0.05; <ce:sup loc="pre">ââ</ce:sup>p &lt; 0.01; <ce:sup loc="pre">âââ</ce:sup>p &lt; 0.001 compared with control PIP condition (n = 3 independent experiments). See also <ce:cross-ref refid="app3" id="crosref0935">Figure S6</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr5"/></ce:figure><ce:figure id="fig6"><ce:label>Figure 6</ce:label><ce:caption id="cap0035"><ce:simple-para id="fspara0240" view="all">Specification and Functional Characterization of Hormone-Producing Pituitary Placode Derivatives</ce:simple-para><ce:simple-para id="fspara0245" view="all">(A) Schematic illustration of normal pituitary lineage development in vivo (<ce:cross-ref refid="bib49" id="crosref0940">Tabar, 2011</ce:cross-ref>). Examples of hormone-producing cells generated using our modified PIP are listed in bold (ACTH, GH, FSH).</ce:simple-para><ce:simple-para id="fspara0250" view="all">(B) Treatment with SHH from days 7 to 11 of PIP differentiation induced <ce:italic>PITX1</ce:italic> and <ce:italic>SIX6</ce:italic> expression as assessed by qRT-PCR. <ce:italic>PITX1</ce:italic> and <ce:italic>SIX6</ce:italic> mark the pituitary anlage. Low SHH: 20 ng/ml C25II SHH; high SHH: 100 ng/ml C25II SHH + 1 Î¼M purmorphamine.</ce:simple-para><ce:simple-para id="fspara0255" view="all">(C) Immunocytochemical analysis showed expression of SIX6 at the protein level in a subset of clusters in the presence of SHH treatment.</ce:simple-para><ce:simple-para id="fspara0260" view="all">(D) Immunocytochemical analysis for expression of LHX3 at day 16 (upon SHH treatment).</ce:simple-para><ce:simple-para id="fspara0265" view="all">(E-G) Induction of defined endocrine precursor lineages: (E) <ce:italic>TBX19</ce:italic> expression was highly induced by day 20. (F) <ce:italic>PIT1</ce:italic> expression at days 20 and 32 of differentiation (see <ce:cross-ref refid="app3" id="crosref0945">Figure S7</ce:cross-ref>A for treatment paradigm). (G) <ce:italic>GATA2</ce:italic> expression at days 20 and 32 of differentiation.</ce:simple-para><ce:simple-para id="fspara0270" view="all">(H-L) Immunocytochemical evidence of hormone production (H) CGA expression was readily detected by day 16 in SHH-treated PIP cultures. (I) FSH was expressed by day 27. (J) ACTH expression was most abundant in SHH-treated PIP culture by day 30 of differentiation. (K) GH expression at day 30 of differentiation. (L) ELISA measurement of in vitro hormone production after 10 min exposure in HBSS.</ce:simple-para><ce:simple-para id="fspara0275" view="all">(M) Schematic illustration of transplantation paradigm in nude rat host.</ce:simple-para><ce:simple-para id="fspara0280" view="all">(N) ACTH plasma levels in grafted adult nude rats and sham-grafted controls at 4 and 6 weeks after transplantation.</ce:simple-para><ce:simple-para id="fspara0285" view="all">(O) GH plasma levels using a human specific ELISA (6 weeks after transplantation).</ce:simple-para><ce:simple-para id="fspara0290" view="all">(P-R) Histological analysis 6 weeks after transplantation: (P) Robust survival of hNCAM<ce:sup loc="post">+</ce:sup> human cells. (Q) ACTH-expressing and (R) GH-expressing cells in vivo.</ce:simple-para><ce:simple-para id="fspara0295" view="all">Scale bars are 100 Î¼m in (C) and (P); 50 Î¼m in (D), (H)-(J), and (Q)-(S); and 10 Î¼m in (K). Error bar represents SEM. <ce:sup loc="pre">â</ce:sup>p &lt; 0.05; <ce:sup loc="pre">ââ</ce:sup>p &lt; 0.01; <ce:sup loc="pre">âââ</ce:sup>p &lt; 0.001 compared with controls PIP condition in (B), hESC in (E)-(G); n = 3 independent experiments), HBSS without cells in (L), and plasma samples from Matrigel-only injected (Sham) animals in (N) and (O) (n = 3 and n = 5 animals). See also <ce:cross-ref refid="app3" id="crosref0950">Figure S7</ce:cross-ref>.</ce:simple-para></ce:caption><ce:link locator="gr6"/></ce:figure><ce:figure id="fig7"><ce:label>Figure 7</ce:label><ce:caption id="cap0040"><ce:simple-para id="fspara0300" view="all">Proposed Model for the Derivation of Human Placodes from hPSCs</ce:simple-para><ce:simple-para id="fspara0305" view="all">Placode induction is dependent on derepression of BMP signaling using dSMADi protocol. Continuous BMP repression induced CNS fates; derepression of BMP in combination with the inhibition of FGF signaling by SU5402 triggers epidermal fates. Preplacodal cells can be further patterned toward specific placode fates by modulating FGF, BMP, or SHH signaling at day 7 of differentiation leading to functional lens, trigeminal neuron, and anterior pituitary derivatives.</ce:simple-para></ce:caption><ce:link locator="gr7"/></ce:figure></ce:floats><head><ce:article-footnote><ce:note-para id="ntpara0010" view="all">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</ce:note-para></ce:article-footnote><ce:dochead id="dhead0010"><ce:textfn>Article</ce:textfn></ce:dochead><ce:title id="title0010">Specification of Functional Cranial Placode Derivatives from Human Pluripotent Stem Cells</ce:title><ce:author-group id="augrp0010"><ce:author id="au1"><ce:given-name>Zehra</ce:given-name><ce:surname>Dincer</ce:surname><ce:cross-ref refid="aff1" id="crosref0010"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0015"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:cross-ref refid="aff4" id="crosref0020"><ce:sup loc="post">4</ce:sup></ce:cross-ref></ce:author><ce:author id="au2"><ce:given-name>Jinghua</ce:given-name><ce:surname>Piao</ce:surname><ce:cross-ref refid="aff1" id="crosref0025"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff3" id="crosref0030"><ce:sup loc="post">3</ce:sup></ce:cross-ref></ce:author><ce:author id="au3"><ce:given-name>Lei</ce:given-name><ce:surname>Niu</ce:surname><ce:cross-ref refid="aff1" id="crosref0035"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0040"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au4"><ce:given-name>Yosif</ce:given-name><ce:surname>Ganat</ce:surname><ce:cross-ref refid="aff1" id="crosref0045"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0050"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au5"><ce:given-name>Sonja</ce:given-name><ce:surname>Kriks</ce:surname><ce:cross-ref refid="aff1" id="crosref0055"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0060"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au6"><ce:given-name>Bastian</ce:given-name><ce:surname>Zimmer</ce:surname><ce:cross-ref refid="aff1" id="crosref0065"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0070"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au7"><ce:given-name>Song-Hai</ce:given-name><ce:surname>Shi</ce:surname><ce:cross-ref refid="aff1" id="crosref0075"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0080"><ce:sup loc="post">2</ce:sup></ce:cross-ref></ce:author><ce:author id="au8"><ce:given-name>Viviane</ce:given-name><ce:surname>Tabar</ce:surname><ce:cross-ref refid="aff1" id="crosref0085"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff3" id="crosref0090"><ce:sup loc="post">3</ce:sup></ce:cross-ref></ce:author><ce:author id="au9"><ce:given-name>Lorenz</ce:given-name><ce:surname>Studer</ce:surname><ce:cross-ref refid="aff1" id="crosref0095"><ce:sup loc="post">1</ce:sup></ce:cross-ref><ce:cross-ref refid="aff2" id="crosref0100"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:cross-ref refid="aff3" id="crosref0105"><ce:sup loc="post">3</ce:sup></ce:cross-ref><ce:cross-ref refid="cor1" id="crosref0110"><ce:sup loc="post">â</ce:sup></ce:cross-ref><ce:e-address type="email" id="eadd0010">studerl@mskcc.org</ce:e-address></ce:author><ce:affiliation id="aff1"><ce:label>1</ce:label><ce:textfn>Center for Stem Cell Biology, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065, USA</ce:textfn></ce:affiliation><ce:affiliation id="aff2"><ce:label>2</ce:label><ce:textfn>Developmental Biology Program, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065, USA</ce:textfn></ce:affiliation><ce:affiliation id="aff3"><ce:label>3</ce:label><ce:textfn>Department of Neurosurgery, Sloan-Kettering Institute, 1275 York Ave, New York, NY 10065, USA</ce:textfn></ce:affiliation><ce:affiliation id="aff4"><ce:label>4</ce:label><ce:textfn>Weill Graduate School of Medical Sciences of Cornell University, New York, NY 10021, USA</ce:textfn></ce:affiliation><ce:correspondence id="cor1"><ce:label>â</ce:label><ce:text>Corresponding author</ce:text></ce:correspondence></ce:author-group><ce:date-received day="1" month="10" year="2012"/><ce:date-revised day="15" month="9" year="2013"/><ce:date-accepted day="30" month="10" year="2013"/><ce:miscellaneous id="misc0010">Published: November 27, 2013</ce:miscellaneous><ce:abstract id="abs0010" view="all" class="author"><ce:section-title id="sectitle0010">Summary</ce:section-title><ce:abstract-sec id="abssec0010" view="all"><ce:simple-para id="abspara0010" view="all">Cranial placodes are embryonic structures essential for sensory and endocrine organ development. Human placode development has remained largely inaccessible despite the serious medical conditions caused by the dysfunction of placode-derived tissues. Here, we demonstrate the efficient derivation of cranial placodes from human pluripotent stem cells. Timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Concomitant inhibition of fibroblast growth factor signaling disrupts placode derivation and induces surface ectoderm. Further fate specification at the preplacode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers, and anterior pituitary hormone-producing cells that upon transplantation produce human growth hormone and adrenocorticotropic hormone in vivo. Our results establish a powerful experimental platform to study human cranial placode development and set the stage for the development of human cell-based therapies in sensory and endocrine disease.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="graphical" id="abs0015" view="all"><ce:section-title id="sectitle0015">Graphical Abstract</ce:section-title><ce:abstract-sec id="abssec0015" view="all"><ce:simple-para id="abspara0015" view="all"><ce:display><ce:figure id="undfig1"><ce:link locator="fx1"/></ce:figure></ce:display></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="author-highlights" id="abs0020" view="all"><ce:section-title id="sectitle0020">Highlights</ce:section-title><ce:abstract-sec id="abssec0020" view="all"><ce:simple-para id="abspara0020" view="all"><ce:list id="ulist0010"><ce:list-item id="u0010"><ce:label>â¢</ce:label><ce:para id="p0010" view="all">Timed withdrawal of BMP inhibitor is sufficient to induce placode fates from hESCs</ce:para></ce:list-item><ce:list-item id="u0015"><ce:label>â¢</ce:label><ce:para id="p0015" view="all">Timed FGF inhibition suppresses placode fate and induces epidermal lineage</ce:para></ce:list-item><ce:list-item id="u0020"><ce:label>â¢</ce:label><ce:para id="p0020" view="all">Placode-derived trigeminal neurons are functional in vitro and engraft in vivo</ce:para></ce:list-item><ce:list-item id="u0025"><ce:label>â¢</ce:label><ce:para id="p0025" view="all">Pituitary placode-derived cells are capable of hormone release in vitro and in vivo</ce:para></ce:list-item></ce:list></ce:simple-para></ce:abstract-sec></ce:abstract><ce:abstract class="teaser" id="abs0025" view="all"><ce:abstract-sec id="abssec0025" view="all"><ce:simple-para id="abspara0025" view="all">Cranial placodes are essential for the development of sensory and endocrine organs. Here, Studer and colleagues report the efficient derivation of cranial placodes from human pluripotent stem cells. They demonstrate how to obtain specific placode derivatives such as trigeminal ganglia capable of in vivo engraftment, mature lens fibers, and anterior pituitary cells capable of producing human GH and ACTH in vivo. Their results establish a platform for studying human cranial placode development and for applications of placode derivatives in regenerative medicine.</ce:simple-para></ce:abstract-sec></ce:abstract></head><body view="all"><ce:sections><ce:section id="sec1" view="all"><ce:section-title id="sectitle0025">Introduction</ce:section-title><ce:para id="p0030" view="all">Cranial placodes give rise to cells of the sensory organs, including the optic lens, the nasal epithelium, otic structures, the adenohypophysis, and a subset of cranial nerves such as the trigeminal ganglia. During development, sensory placodes are formed at the interface of the nonneural ectoderm and neural plate, surrounding the anterior portion of the future CNS (<ce:cross-ref refid="app3" id="crosref0115">Figure S1</ce:cross-ref>A). Defects in placode development cause a wide spectrum of human congenital malformations ranging from blindness and deafness to hormone imbalance or loss of smell (<ce:cross-refs refid="bib1 bib5 bib41" id="crosrefs0010">Abdelhak et al., 1997; Baker and Bronner-Fraser, 2001; Ruf et al., 2004</ce:cross-refs>). To date, cranial placode development has been characterized in model organisms, including the frog, zebrafish, chicken, and, to a lesser extent, the mouse (<ce:cross-refs refid="bib5 bib9 bib43" id="crosrefs0015">Baker and Bronner-Fraser, 2001; Bhattacharyya and Bronner-Fraser, 2004; Schlosser, 2006</ce:cross-refs>). However, human placode development has remained largely unexplored due to lack of access to early human tissue and specific placode markers.</ce:para><ce:para id="p0035" view="all">Human pluripotent stem cells (hPSCs), including human embryonic (hESCs), and human induced pluripotent stem cells (hiPSCs) have the potential to self-renew, while retaining a very broad differentiation potential. Over the last few years, protocols have been developed for directing the fate of hESCs into specific cell lineages. The derivation of CNS cells was among the first hESC differentiation protocols developed in the field (<ce:cross-refs refid="bib40 bib53" id="crosrefs0020">Reubinoff et al., 2001; Zhang et al., 2001</ce:cross-refs>). The differentiation of hESCs into cells of the peripheral nervous system has also been achieved (<ce:cross-refs refid="bib24 bib32" id="crosrefs0025">Lee et al., 2007; Menendez et al., 2011</ce:cross-refs>). In contrast to the successful derivation and application of defined CNS-and neural-crest (NC)-derived cell types, there has been limited success on modeling cranial placode development in hPSCs.</ce:para><ce:para id="p0040" view="all">Recently, we developed a neural induction strategy based on the concomitant inhibition of the Bone Morphogenetic Protein (BMP) and TGF-Î²/Activin/Nodal signaling pathways (dual-SMAD inhibition [dSMADi] (<ce:cross-ref refid="bib10" id="crosref0120">Chambers et al., 2009</ce:cross-ref>). Exposure to Noggin (N) and SB431542 (SB) leads to the synchronized, rapid and efficient differentiation of hPSCs into CNS fates. Here, we report that derepression of endogenous BMP signaling during dSMADi is sufficient for the selective induction of human cranial placodes. Using the placode induction protocol (PIP) &gt;70% of all cells adopt a SIX1<ce:sup loc="post">+</ce:sup> cranial placode precursor fate by day 11 of differentiation. We further identify a preplacodal lineage competent to differentiate into selective placode fates including trigeminal sensory neurons, mature lens fibers, and hormone-producing anterior pituitary cells. Trigeminal sensory neurons are characterized by marker expression, electrophysiology, and by transplantation into the developing chick embryo and the adult mouse CNS. Finally, we report the derivation of human pituitary cells producing growth hormone (GH) and adrenocorticotropic hormone (ACTH) hormones in vitro and in vivo.</ce:para></ce:section><ce:section id="sec2" view="all"><ce:section-title id="sectitle0030">Results</ce:section-title><ce:section id="sec2.1" view="all"><ce:section-title id="sectitle0035">Derepression of Endogenous BMP Signaling Induces Placode at the Expense of Neuroectoderm</ce:section-title><ce:para id="p0045" view="all">To address whether the dSMADi protocol is suitable for the derivation of placodal cells, we first defined a set of appropriate placode markers. Based on studies in model organisms, we hypothesized that members of the SIX, EYA, and DLX family of transcription factors (<ce:cross-refs refid="bib5 bib43" id="crosrefs0030">Baker and Bronner-Fraser, 2001; Schlosser, 2006</ce:cross-refs>) mark human placode fate. Within the ectodermal lineage, SIX1 is placode specific, marking both the early preplacodal region and the various specific placodes (<ce:cross-ref refid="bib43" id="crosref0125">Schlosser, 2006</ce:cross-ref>). Based on studies in the chick embryo, placode induction relies on a complex interplay of fibroblast growth factor (FGF), BMP, and WNT signals during early ectodermal patterning in vivo (<ce:cross-ref refid="bib26" id="crosref0130">Litsiou et al., 2005</ce:cross-ref>). Activity of BMPs within the ectoderm is thought to be particularly critical in allocating fates. A model has been proposed initially whereby high levels of signaling promote an epidermal fate, moderate levels induce placodes, intermediate levels specify NC, and a complete absence of BMP activity is required for neural plate formation (<ce:cross-ref refid="bib51" id="crosref0135">Wilson et al., 1997</ce:cross-ref>). More recent studies have revised the original model by confirming an early role for BMP signaling in establishing placode competence (<ce:cross-ref refid="bib22" id="crosref0140">Kwon et al., 2010</ce:cross-ref>), whereas the subsequent stage was shown to require BMP inhibition rather than BMP activation (<ce:cross-refs refid="bib2 bib22 bib26" id="crosrefs0035">Ahrens and Schlosser, 2005; Kwon et al., 2010; Litsiou et al., 2005</ce:cross-refs>).</ce:para><ce:para id="p0050" view="all">To test whether early BMP exposure promotes the derivation of SIX1<ce:sup loc="post">+</ce:sup> placodal cells, we exposed SB (the TGF-Î² inhibitor) -treated hESCs to various concentrations of BMP4. However, addition of BMP4 in the presence of SB caused a dramatic morphological change and triggered induction of <ce:italic>CDX2</ce:italic> (<ce:cross-ref refid="app3" id="crosref0145">Figures S1</ce:cross-ref>B and S1C), similar to the BMP-mediated induction of trophectoderm-like lineages reported previously (<ce:cross-ref refid="bib52" id="crosref0150">Xu et al., 2002</ce:cross-ref>). We next tested whether timed withdrawal of the BMP inhibitor Noggin during Noggin/SB431542 (N-SB)-mediated differentiation could induce placodal fates via derepressing endogenous BMP signaling. We performed a time-course analysis during which we removed Noggin at different time points of the N-SB protocol (<ce:cross-ref refid="fig1" id="crosref0155">Figure 1</ce:cross-ref><ce:float-anchor refid="fig1"/>A). Gene expression analysis at day 11 revealed a robust induction of <ce:italic>DLX3</ce:italic>, <ce:italic>SIX1</ce:italic>, and <ce:italic>EYA1</ce:italic> (<ce:cross-ref refid="fig1" id="crosref0160">Figure 1</ce:cross-ref>B) upon withdrawal of Noggin at days 2 or 3 of differentiation. In contrast, Noggin withdrawal at day 1 of differentiation led to the induction of <ce:italic>EYA1</ce:italic> in the absence of <ce:italic>SIX1</ce:italic> expression and triggered morphological changes as well as <ce:italic>CDX2</ce:italic> expression, suggesting trophectodermal differentiation (though CDX2 and EYA1 can also be expressed in hESC-derived mesodermal lineages [<ce:cross-ref refid="bib8" id="crosref0165">Bernardo et al., 2011</ce:cross-ref>]). Our data indicate that <ce:italic>EYA1</ce:italic> is expressed in both trophectodermal and placodal lineages, and that coexpression with <ce:italic>SIX1</ce:italic> is required to define placodal lineage. Immunocytochemical analysis of hESC progeny at day 11 of differentiation demonstrated that Noggin withdrawal at day 3 (PIP conditions) induced a switch from 82% PAX6<ce:sup loc="post">+</ce:sup> neuroectodermal cells under N-SB conditions to 71% SIX1<ce:sup loc="post">+</ce:sup> putative placode precursor cells under PIP (<ce:cross-ref refid="fig1" id="crosref0170">Figures 1</ce:cross-ref>C, 1D, and <ce:cross-ref refid="app3" id="crosref0175">S1</ce:cross-ref>D). SIX1<ce:sup loc="post">+</ce:sup> clusters expressed other placodal markers such as EYA1, DACH1, and FOXG1 (BF1) (<ce:cross-ref refid="fig1" id="crosref0180">Figure 1</ce:cross-ref>E). DACH1 is also expressed in anterior neuroectodermal cells (<ce:cross-ref refid="bib15" id="crosref0185">Elkabetz et al., 2008</ce:cross-ref>) marking neural rosettes, whereas in PIP-treated cultures DACH1 marks placodal clusters (<ce:cross-ref refid="app3" id="crosref0190">Figure S1</ce:cross-ref>E). Temporal analysis of gene expression under PIP conditions revealed rapid downregulation of pluripotency markers (<ce:italic>OCT4</ce:italic>, <ce:italic>NANOG</ce:italic>), as well as markers of trophectoderm (<ce:italic>CDX2</ce:italic>) (<ce:cross-ref refid="fig1" id="crosref0195">Figure 1</ce:cross-ref>F), mesoderm (<ce:italic>T</ce:italic>), and endoderm (<ce:italic>SOX17</ce:italic>) (<ce:cross-ref refid="fig1" id="crosref0200">Figure 1</ce:cross-ref>G). SIX1 expression in placode was confirmed in human primary tissue (Carnegie Stage 15, â¼5.5 weeks postconception [p.c.]; data not shown). SIX1 is also expressed in precursors of skeletal muscle, thymus, and kidney cells. However, we did not detect expression of skeletal muscle (<ce:italic>MYOD</ce:italic>), endoderm (<ce:italic>SOX17</ce:italic>), or mesoderm (<ce:italic>Brachyury</ce:italic> [<ce:italic>T</ce:italic>]) markers during PIP confirming that the hESC-derived SIX1<ce:sup loc="post">+</ce:sup> cells are of placode identity. We also observed very few (&lt;1%) NC lineage cells under PIP conditions based on SOX10 expression by immunocytochemistry and <ce:italic>SOX10::GFP</ce:italic> (<ce:cross-refs refid="bib11 bib35" id="crosrefs0045">Chambers et al., 2012; Mica et al., 2013</ce:cross-refs>) reporter line expression (<ce:cross-ref refid="app3" id="crosref0205">Figure S1</ce:cross-ref>F). Induction of cranial placode markers was observed by day 5 with <ce:italic>FOXG1</ce:italic> preceding expression of <ce:italic>SIX1</ce:italic> and <ce:italic>DLX3</ce:italic> (<ce:cross-ref refid="fig1" id="crosref0210">Figure 1</ce:cross-ref>H). The PIP protocol was validated in multiple hESC and hiPSC lines (<ce:cross-ref refid="app3" id="crosref0215">Figures S1</ce:cross-ref>G and S1H).</ce:para><ce:para id="p0055" view="all">To further validate the identity of hESC-derived placodal precursors, we made use of a conserved Eya1 enhancer element (<ce:cross-ref refid="bib19" id="crosref0220">Ishihara et al., 2008</ce:cross-ref>). We readily observed GFP expression following nucleofection of the enhancer in olfactory placode but not in age-matched midbrain cultures (<ce:cross-ref refid="app3" id="crosref0225">Figures S1</ce:cross-ref>I-S1J) confirming specificity. In hESC-derived placode, we observed an 8-fold increase in the percentage of cells with enhancer activity in PIP versus N-SB (<ce:cross-ref refid="app3" id="crosref0230">Figure S1</ce:cross-ref>K).</ce:para></ce:section><ce:section id="sec2.2" view="all"><ce:section-title id="sectitle0040">Microarray Analysis Reveals Human Placode Progenitor Gene Expression</ce:section-title><ce:para id="p0060" view="all">We next performed temporal transcriptome analysis to establish an unbiased molecular assessment of the in vitro placode induction process. RNA was collected at five time points in triplicates (days 1, 3, 5, 7, and 11) in control N-SB- versus PIP-treated cultures (<ce:cross-ref refid="fig2" id="crosref0235">Figures 2</ce:cross-ref>A-2E<ce:float-anchor refid="fig2"/>; all raw data are available at GEO accession no. <ce:inter-ref xlink:href="ncbi-geo:GSE51533" id="intref0010" xlink:type="simple">GSE51533</ce:inter-ref>). Prior to microarray analysis, the quality of each sample was verified for expression of a panel of placode markers (<ce:italic>SIX1</ce:italic>, <ce:italic>DLX3</ce:italic>, <ce:italic>EYA1</ce:italic>) and the absence of other lineage markers (<ce:italic>FOXA2</ce:italic>, endoderm; <ce:italic>SOX17</ce:italic>, endoderm; <ce:italic>MYOD</ce:italic>, skeletal muscle; <ce:italic>CDX2</ce:italic>, trophoblast; and <ce:italic>T</ce:italic>, mesoderm). Cluster and principal component analyses showed a temporal segregation of the transcriptome data in PIP versus N-SB-treated cells by day 7 of differentiation (<ce:cross-ref refid="fig2" id="crosref0240">Figures 2</ce:cross-ref>A and <ce:cross-ref refid="app3" id="crosref0245">S2</ce:cross-ref>A). Transcriptome data also defined a set of genes that distinguish placodal from neuroectodermal fate (<ce:cross-ref refid="app3" id="crosref0250">Tables S1</ce:cross-ref> and <ce:cross-ref refid="app3" id="crosref0255">S2</ce:cross-ref>).</ce:para><ce:para id="p0065" view="all">To gain insight into specific genes differentially expressed during placode induction, we performed pairwise comparisons for each differentiation time point (<ce:cross-ref refid="fig2" id="crosref0260">Figures 2</ce:cross-ref>B-2E). Among the most highly enriched transcripts under PIP condition were known placode markers such as <ce:italic>GATA3</ce:italic>, <ce:italic>DLX5</ce:italic>, <ce:italic>DLX3</ce:italic>, <ce:italic>TFAP2A</ce:italic>, and <ce:italic>TFAP2C</ce:italic>. SIX1 was significantly upregulated in the microarray analysis by day 9 of differentiation, though it was not among the 20 most differentially regulated genes. Differential expression for these and additional genes was verified by quantitative RT-PCR (qRT-PCR) (<ce:cross-ref refid="app3" id="crosref0265">Figure S2</ce:cross-ref>B). We also observed significant transcriptional changes in WNT and BMP pathway components such as an increase in the WNT pathway inhibitor DKK-1 and BMP antagonists, such as <ce:italic>GREMLIN-1</ce:italic> and <ce:italic>BAMBI</ce:italic> (<ce:cross-ref refid="fig2" id="crosref0270">Figures 2</ce:cross-ref>B-2D), which are known transcriptional targets of BMP signaling (<ce:cross-ref refid="bib17" id="crosref0275">Grotewold et al., 2001</ce:cross-ref>). Interestingly, we also noticed induction of <ce:italic>ISL1</ce:italic>, a well-known marker for sensory neurons, motoneurons, heart progenitors, and pancreatic islet cells (<ce:cross-ref refid="bib18" id="crosref0280">Hunter and Rhodes, 2005</ce:cross-ref>). Based on the early onset of <ce:italic>ISL1</ce:italic> expression and the absence of mesodermal fates, we surmised that under PIP conditions ISL1 represents an early human placode marker. <ce:italic>ISL1</ce:italic> was one of the first makers induced during PIP differentiation. Similar to TFAP2A and SIX1 (<ce:cross-ref refid="fig2" id="crosref0285">Figure 2</ce:cross-ref>F), ISL1 protein remained expressed in the majority of cells by day 11 of differentiation partially colocalizing with SIX1 (<ce:cross-ref refid="fig2" id="crosref0290">Figure 2</ce:cross-ref>G). Another placode marker identified by our microarray expression data is <ce:italic>OVOL2</ce:italic>, a member of the Ovo family of zinc-finger transcription factors. <ce:italic>OVOL2</ce:italic> was enriched during PIP by day 5 of differentiation, and placode clusters showed strong immunoreactivity for OVOL2 (<ce:cross-ref refid="fig2" id="crosref0295">Figure 2</ce:cross-ref>H). In contrast, <ce:italic>OVOL2</ce:italic> was downregulated under conditions promoting CNS (N-SB) or neural crest (N-SB/CHIR [<ce:cross-refs refid="bib11 bib35" id="crosrefs0050">Chambers et al., 2012; Mica et al., 2013</ce:cross-refs>]) fates (<ce:cross-ref refid="fig2" id="crosrefs0055">Figure 2</ce:cross-ref>I).</ce:para><ce:para id="p0070" view="all">We identified additional differentially expressed genes during anterior placode specification, including <ce:italic>FOXC1</ce:italic> and <ce:italic>HAPNL1</ce:italic> (also known as <ce:italic>CRTL1</ce:italic>). <ce:italic>FOXC1</ce:italic> marks the lens placode during chick development (<ce:cross-ref refid="bib4" id="crosref0300">Bailey et al., 2006</ce:cross-ref>) but may also be expressed at the preplacode stage (<ce:cross-ref refid="bib42" id="crosref0305">Sasaki and Hogan, 1993</ce:cross-ref>). <ce:italic>HAPNL1</ce:italic> was one of the most differentially expressed genes in PIP and was previously shown to be expressed in the surface ectoderm and chick neural plate border (<ce:cross-ref refid="bib13" id="crosref0310">Colas and Schoenwolf, 2003</ce:cross-ref>). Gene ontology (GO) analysis, using DAVID (<ce:inter-ref xlink:href="http://david.abcc.ncifcrf.gov/" id="intref0015" xlink:type="simple">http://david.abcc.ncifcrf.gov/</ce:inter-ref>) (<ce:cross-ref refid="bib14" id="crosref0315">Dennis et al., 2003</ce:cross-ref>), indicated that transcripts highly enriched in PIP versus N-SB conditions at day 7 and day 9 of differentiation are associated with sensory organ development, BMP and WNT pathways, as well as ectoderm and epidermis development (<ce:cross-ref refid="app3" id="crosref0320">Figure S2</ce:cross-ref>C). The total number of differentially expressed genes increased by day 7 of differentiation (<ce:cross-ref refid="app3" id="crosref0325">Figures S2</ce:cross-ref>D and S2E) matching the proposed time frame for placode commitment. In summary, our molecular analyses present a roadmap of human placode development and an important resource for future functional studies.</ce:para></ce:section><ce:section id="sec2.3" view="all"><ce:section-title id="sectitle0045">Early Treatment with FGF Inhibitor Suppresses Placode and Induces Surface Ectoderm Fate</ce:section-title><ce:para id="p0075" view="all">Lineage studies in several vertebrate species indicate that cranial placode precursors originate from the surface ectoderm and are induced by signals emanating from the adjacent neuroectoderm (<ce:cross-ref refid="bib39" id="crosref0330">Pieper et al., 2012</ce:cross-ref>), rather than being of neural origin. However, no such data are available for human development. The putative timing of human placode induction (approximately day 20 p.c.) (<ce:cross-ref refid="bib36" id="crosref0335">O'Rahilly, 1987</ce:cross-ref>) makes this a stage largely inaccessible to experimental manipulations. Gene expression data during PIP indicate that <ce:italic>TFAP2A</ce:italic> is one of the earliest upregulated and differentially expressed genes (<ce:cross-ref refid="fig2" id="crosref0340">Figures 2</ce:cross-ref>B-2E). During mouse development, early expression of the orthologous gene <ce:italic>Tcfap2a</ce:italic> (E7.5) is restricted to the future surface ectoderm (<ce:cross-ref refid="bib3" id="crosref0345">Arkell and Beddington, 1997</ce:cross-ref>).</ce:para><ce:para id="p0080" view="all">The induction of <ce:italic>TFAP2A</ce:italic> was first detected at day 5 of PIP, whereas absent in N-SB protocol (<ce:cross-ref refid="fig3" id="crosref0350">Figure 3</ce:cross-ref><ce:float-anchor refid="fig3"/>A) suggesting that the period between days 3 and 5 of PIP corresponds to the commitment toward surface ectoderm. <ce:italic>SIX1</ce:italic> was induced 2 days later than <ce:italic>TFAP2A</ce:italic> (<ce:cross-ref refid="fig3" id="crosref0355">Figures 3</ce:cross-ref>A and 3B) further pointing to a surface ectoderm intermediate. In vivo genetic studies indicate that high levels of BMPs in the absence of FGF signaling promote epidermal fate, whereas placodal cells are established at reduced levels of BMPs upon activation of FGFs (<ce:cross-refs refid="bib21 bib26" id="crosrefs0060">Kudoh et al., 2004; Litsiou et al., 2005</ce:cross-refs>). Therefore, we tested whether blocking endogenous FGF signaling under PIP conditions disrupts placode induction and triggers epidermal fate. Exposure to SU5402, a small molecule inhibiting FGF signaling, from day 3 to 11 of differentiation (<ce:cross-ref refid="app3" id="crosref0360">Figure S3</ce:cross-ref>A) suppressed the emergence of SIX1<ce:sup loc="post">+</ce:sup> clusters while maintaining TFAP2A expression (<ce:cross-ref refid="fig3" id="crosref0365">Figure 3</ce:cross-ref>C). Quantification of <ce:italic>SIX1</ce:italic> and <ce:italic>TFAP2A</ce:italic> gene expression at day 11 confirmed a complete loss of placode marker expression (<ce:cross-ref refid="fig3" id="crosref0370">Figure 3</ce:cross-ref>D), whereas <ce:italic>TFAP2A</ce:italic> expression was maintained. The ectodermal precursor identity of TFAP2A<ce:sup loc="post">+</ce:sup> cells was supported by the expression of the epidermal precursor marker <ce:italic>KRT8</ce:italic> in PIP + SU5402-treated cultures (<ce:cross-ref refid="fig3" id="crosref0375">Figure 3</ce:cross-ref>E). Furthermore, long-term cultures (days 42-60) showed robust induction of the mature keratinocyte marker <ce:italic>KRT14</ce:italic> (<ce:cross-ref refid="fig3" id="crosref0380">Figure 3</ce:cross-ref>F) and formed E-CADHERIN-positive patches with KRT14-immunoreactive cells at the periphery (<ce:cross-ref refid="app3" id="crosref0385">Figure S3</ce:cross-ref>B). Analysis of the proliferative capacity of the epidermal precursors showed KI67 expression primarily in E-CADHERIN<ce:sup loc="post">+</ce:sup>/KRT14<ce:sup loc="post">-</ce:sup> cells. Cell proliferation decreased by day 60 concomitant with an increased percentage of cells expressing KRT14 (<ce:cross-ref refid="fig3" id="crosref0390">Figures 3</ce:cross-ref>G and <ce:cross-ref refid="app3" id="crosref0395">S3</ce:cross-ref>C). In addition to the requirement for endogenous FGF signaling, we observed low WNT and BMP levels as other important parameters for the transition from surface ectoderm (day3) to early placode fate. Exposure to high concentrations of CHIR or BMP4 suppressed placode at the expense of NC or putative trophectoderm, respectively (<ce:cross-ref refid="app3" id="crosref0400">Figures S3</ce:cross-ref>D and S3E).</ce:para></ce:section><ce:section id="sec2.4" view="all"><ce:section-title id="sectitle0050">Placode Precursors Efficiently Differentiate into Trigeminal-type Sensory Neurons</ce:section-title><ce:para id="p0085" view="all">Cranial placodes give rise to a broad range of specialized cell types, including hormone-producing cells of the anterior pituitary gland, structural cells such as lens fibers in the eye, and sensory neurons including trigeminal neurons (<ce:cross-ref refid="fig4" id="crosref0405">Figure 4</ce:cross-ref><ce:float-anchor refid="fig4"/>A). Placodes can be characterized by the expression of specific PAX genes (<ce:cross-ref refid="bib31" id="crosref0410">McCauley and Bronner-Fraser, 2002</ce:cross-ref>). We observed that under standard PIP conditions most SIX1<ce:sup loc="post">+</ce:sup> clusters coexpressed PAX3 (<ce:cross-ref refid="fig4" id="crosref0415">Figure 4</ce:cross-ref>B), suggesting ophthalmic trigeminal placode identity (<ce:cross-refs refid="bib30 bib47" id="crosrefs0065">McCabe et al., 2004; Stark et al., 1997</ce:cross-refs>). The spontaneous generation of HNK1<ce:sup loc="post">+</ce:sup> (<ce:cross-ref refid="bib34" id="crosref0420">Metcalfe et al., 1990</ce:cross-ref>) cells with neuronal morphologies and coexpression of ISL1 confirmed peripheral sensory neuron identity (<ce:cross-ref refid="fig4" id="crosref0425">Figure 4</ce:cross-ref>C). To further ascertain the placode origin of the sensory neurons under PIP conditions, we assessed coexpression of neuronal markers with SIX1 (<ce:cross-ref refid="fig4" id="crosref0430">Figures 4</ce:cross-ref>D and <ce:cross-ref refid="app3" id="crosref0435">S4</ce:cross-ref>A). Lack of SOX10 expression during PIP-based sensory neuron differentiation ruled out a neural crest origin. By day 20 of differentiation (7 days after replating), the cells formed ganglia-like structures with neurons extending long, radial processes and with nuclear expression of BRN3A (<ce:cross-ref refid="fig4" id="crosref0440">Figures 4</ce:cross-ref>D and 4E), a sensory neuron marker. Most neurons retained ISL1 expression by day 42 of differentiation and acquired expression of the peripheral neuron marker peripherin (<ce:cross-ref refid="fig4" id="crosref0445">Figures 4</ce:cross-ref>F and <ce:cross-ref refid="app3" id="crosref0450">S4</ce:cross-ref>B). Immunocytochemical analysis for neurotransmitter phenotypes revealed expression of glutamate (<ce:cross-ref refid="fig4" id="crosref0455">Figure 4</ce:cross-ref>G) but lack of expression of TH and GABA (data not shown). These data are compatible with the generation of glutamatergic trigeminal sensory neurons. Gene expression analysis showed induction of <ce:italic>RUNX1</ce:italic> (<ce:cross-ref refid="fig4" id="crosref0460">Figures 4</ce:cross-ref>H and <ce:cross-ref refid="app3" id="crosref0465">S4</ce:cross-ref>C) and <ce:italic>RET</ce:italic> (<ce:cross-ref refid="app3" id="crosref0470">Figure S4</ce:cross-ref>D), indicating sensory/nociceptive lineage. Expression of TRK receptors (<ce:cross-ref refid="fig4" id="crosrefs0070">Figures 4</ce:cross-ref>I and <ce:cross-ref refid="app3" id="crosref0475">S4</ce:cross-ref>E) including <ce:italic>NTRK1</ce:italic> and <ce:italic>NTRK2</ce:italic> points to the presence of both nociceptive and nonnociceptive sensory neurons (<ce:cross-ref refid="app3" id="crosref0480">Figures S4</ce:cross-ref>E-S4G). Diagnostic markers of nociceptive neuron identity include expression of specific sodium channels (<ce:italic>SCN9A</ce:italic>, <ce:italic>SCN10A</ce:italic>, <ce:italic>SCN11A</ce:italic>; <ce:cross-ref refid="fig4" id="crosref0485">Figure 4</ce:cross-ref>J) as well as classic pain receptors such as the capsaicin receptor (<ce:italic>TRPV1</ce:italic>), the receptor for cold sensation (<ce:italic>TRPM8</ce:italic>), and the P2X3 receptor critical for sensation of inflammatory pain mediated by ATP (<ce:cross-ref refid="fig4" id="crosref0490">Figure 4</ce:cross-ref>K). Gene expression analysis in long-term trigeminal neuronal cultures (day 55) showed sustained expression of <ce:italic>RET1</ce:italic> and <ce:italic>RUNX1</ce:italic> (<ce:cross-ref refid="app3" id="crosref0495">Figures S4</ce:cross-ref>C and S4D).</ce:para><ce:para id="p0090" view="all">Functional analysis of placode-derived sensory neurons was performed by whole-cell patch-clamp recordings (<ce:cross-ref refid="app3" id="crosref0500">Figure S4</ce:cross-ref>G). Neurons were filled with Lucifer yellow from the recording pipette exhibiting either bipolar or tripolar morphologies (<ce:cross-ref refid="fig4" id="crosref0505">Figures 4</ce:cross-ref>L and 4M). Responses were measured to a series of hyperpolarizing and depolarizing pulses (<ce:cross-ref refid="fig4" id="crosref0510">Figure 4</ce:cross-ref>N). The hESC-derived neurons produced single action potentials at a threshold depolarization matching the functional properties reported for primary embryonic trigeminal neurons (<ce:cross-ref refid="bib16" id="crosref0515">Grigaliunas et al., 2002</ce:cross-ref>). The average resting membrane potential (RMP) was -65.6 Â± 6.7 (<ce:cross-ref refid="fig4" id="crosref0520">Figures 4</ce:cross-ref>L and 4M). Passive membrane and action potential properties were comparable between bipolar and tripolar sensory neurons as summarized in (<ce:cross-ref refid="fig4" id="crosref0525">Figure 4</ce:cross-ref>O) suggesting that two morphologically distinct populations do not reflect functionally distinct subgroups. We further assessed the robustness of the trigeminal sensory neuron induction protocol across multiple hESC and hiPSC lines. We observed comparable percentages of ISL1- and BRN3A-expressing neurons across lines (<ce:cross-ref refid="app3" id="crosref0530">Figure S4</ce:cross-ref>H).</ce:para></ce:section><ce:section id="sec2.5" view="all"><ce:section-title id="sectitle0055">In Vivo Analysis of hESC-Derived Trigeminal Neurons in the Developing Chick Embryo and Adult Mouse CNS</ce:section-title><ce:para id="p0095" view="all">To assess the in vivo properties of hESC-derived trigeminal placode precursors, PIP-induced neuronal clusters, derived from a constitutively GFP-positive hESC line (<ce:cross-ref refid="app3" id="crosref0535">Figures S5</ce:cross-ref>A and S5B), were injected into the developing chick embryo targeting the early trigeminal anlage at H&amp;H stage 10-12 (<ce:cross-ref refid="app3" id="crosref0540">Figure S5</ce:cross-ref>C). Human cells were identified based on GFP expression and use of human specific antibodies against cytoplasmic antigen (hCA). Two days after in ovo transplantation, surviving GFP<ce:sup loc="post">+</ce:sup> cells were found dispersed in the area of the endogenous chick trigeminal ganglion (<ce:cross-ref refid="fig4" id="crosref0545">Figure 4</ce:cross-ref>P). We observed extensive GFP<ce:sup loc="post">+</ce:sup> human fiber bundles coexpressing hCA and peripherin (<ce:cross-ref refid="fig4" id="crosref0550">Figures 4</ce:cross-ref>Q and 4R). In contrast, no hCA or peripherin expression was detected in the neural tube of the embryo (<ce:cross-ref refid="app3" id="crosref0555">Figure S5</ce:cross-ref>D). The in vivo fiber outgrowth 2 days after transplantation was reminiscent of the extensive in vitro fiber outgrowth of replated trigeminal neuron clusters (<ce:cross-ref refid="app3" id="crosref0560">Figure S5</ce:cross-ref>A). Peripherin expression in vivo (<ce:cross-ref refid="fig4" id="crosref0565">Figure 4</ce:cross-ref>S) confirmed the peripheral neuron identity of the grafted cells.</ce:para><ce:para id="p0100" view="all">We next addressed whether hESC-derived trigeminal neurons can engraft in the adult mouse CNS and project toward their physiological target. The trigeminal nuclei in the brainstem receive afferent innervation from the trigeminal sensory ganglion that is relayed to the contralateral thalamus. The pons was selected as site for transplantation, because it is surgically accessible and located within proximity of the trigeminal brain stem nuclei that receive afferent input from the trigeminal ganglia. Hence, GFP<ce:sup loc="post">+</ce:sup> human trigeminal neuron clusters were injected into adult NOD/SCID mice via stereotactic surgery (see <ce:cross-ref refid="sec4" id="crosref0570">Experimental Procedures</ce:cross-ref>). Histological analysis 4 weeks after transplantation showed survival of GFP<ce:sup loc="post">+</ce:sup> human cell graft in the ventral pons (<ce:cross-ref refid="app3" id="crosref0575">Figure S5</ce:cross-ref>E). Although GFP<ce:sup loc="post">+</ce:sup> cell bodies remained tightly clustered at injection site, GFP<ce:sup loc="post">+</ce:sup> fibers showed extensive projections into the host brain (n = 6) including the endogenous trigeminal nuclei (<ce:cross-ref refid="app3" id="crosref0580">Figure S5</ce:cross-ref>F). Expression of BRN3A confirmed the sensory neuron identity of the cells (<ce:cross-ref refid="app3" id="crosref0585">Figure S5</ce:cross-ref>G). Graft-derived human fiber bundles (hNCAM<ce:sup loc="post">+</ce:sup> and GFP<ce:sup loc="post">+</ce:sup>) were observed emanating from the graft core (<ce:cross-ref refid="app3" id="crosref0590">Figure S5</ce:cross-ref>H). These data demonstrate in vivo survival of trigeminal placode derivatives, differentiation along sensory neuron lineage, and the establishment of axonal projections toward relevant endogenous targets in the embryonic chick and adult mouse brain.</ce:para></ce:section><ce:section id="sec2.6" view="all"><ce:section-title id="sectitle0060">Identification of a Putative Preplacode Stage</ce:section-title><ce:para id="p0105" view="all">Our results indicate that current PIP conditions efficiently induce ophthalmic trigeminal placode fates. To investigate whether other placodal fates can be generated using modified PIP conditions, we first addressed the presence of putative preplacode cells in our culture system. During vertebrate development, the preplacode is characterized as the developmental anlage containing precursor cells competent to respond to signals determining placode identity (<ce:cross-ref refid="bib29" id="crosref0595">Martin and Groves, 2006</ce:cross-ref>). Preplacodal cells in various model organisms have been shown to express Six1 and to coexpress markers of both ectodermal and neural fate. However, the development of a human preplacode remains unexplored. We performed a time-course coexpression analysis for TFAP2A (early ectodermal marker) and PAX6 (early neuroectoderm marker [<ce:cross-ref refid="bib54" id="crosref0600">Zhang et al., 2010</ce:cross-ref>]). During the first 3 days of differentiation, only a few sparse patches of PAX6- or TFAP2A-expressing cells were observed without evidence of coexpression (<ce:cross-ref refid="fig5" id="crosref0605">Figure 5</ce:cross-ref><ce:float-anchor refid="fig5"/>A). At day 5, 2 days following Noggin withdrawal (PIP), there was an increase in the number of TFAP2A<ce:sup loc="post">+</ce:sup> cells (<ce:cross-ref refid="fig5" id="crosref0610">Figure 5</ce:cross-ref>B) under PIP conditions and a concomitant loss of TFAP2A<ce:sup loc="post">+</ce:sup> cells in N-SB (<ce:cross-ref refid="fig5" id="crosref0615">Figure 5</ce:cross-ref>C). At day 7, N-SB conditions yielded PAX6<ce:sup loc="post">+</ce:sup> cells devoid of TFAP2A expression (<ce:cross-ref refid="fig5" id="crosref0620">Figure 5</ce:cross-ref>C), whereas PIP-treated cultures showed extensive coexpression of TFAP2A and PAX6, indicating preplacode identity (<ce:cross-ref refid="fig5" id="crosref0625">Figure 5</ce:cross-ref>B). The emergence of TFAP2A/PAX6 double-positive cells coincided with the onset of <ce:italic>SIX1</ce:italic> gene expression and the emergence of SIX1<ce:sup loc="post">+</ce:sup> clusters around day 7 of differentiation (<ce:cross-ref refid="fig3" id="crosref0630">Figures 3</ce:cross-ref>B and <ce:cross-ref refid="app3" id="crosref0635">S6</ce:cross-ref>A). By day 11, placode clusters were negative for PAX6 but retained expression of TFAP2A (<ce:cross-ref refid="fig5" id="crosref0640">Figure 5</ce:cross-ref>B), suggesting that early anterior PAX6<ce:sup loc="post">+</ce:sup> preplacode cells give rise to PAX6-negative posterior placode populations enriched for PAX3<ce:sup loc="post">+</ce:sup>. This model was further supported by gene expression data showing a robust <ce:italic>PAX3</ce:italic> increase from day 7 to 11 of PIP (<ce:cross-ref refid="fig5" id="crosref0645">Figure 5</ce:cross-ref>D). Treatment with inhibitors of WNT or FGF signaling from day 7 to 11 of PIP suppressed <ce:italic>PAX3</ce:italic> induction (<ce:cross-ref refid="fig5" id="crosref0650">Figure 5</ce:cross-ref>E) while maintaining <ce:italic>PAX6</ce:italic> (<ce:cross-ref refid="fig5" id="crosref0655">Figure 5</ce:cross-ref>F). Our results indicate that endogenous signals contribute to the transition from an anterior PAX6<ce:sup loc="post">+</ce:sup> preplacode to a posterior PAX3<ce:sup loc="post">+</ce:sup> placode lineage. The small number of TFAP2A cells in day 11 N-SB cultures (<ce:cross-ref refid="fig5" id="crosref0660">Figure 5</ce:cross-ref>C) likely represents neural crest precursors (<ce:cross-ref refid="bib10" id="crosref0665">Chambers et al., 2009</ce:cross-ref>) that lack PAX6 expression. Under PIP conditions the percentage of contaminating SOX10<ce:sup loc="post">+</ce:sup> NC cells at day 11 was &lt;1% (<ce:cross-ref refid="app3" id="crosref0670">Figure S1</ce:cross-ref>F).</ce:para></ce:section><ce:section id="sec2.7" view="all"><ce:section-title id="sectitle0065">Treatment with FGF Inhibitor SU5402 at Preplacode Stage Induces Lens Fates</ce:section-title><ce:para id="p0110" view="all">We next tested whether putative preplacode cells can be coaxed into specific placode fates other then trigeminal neurons. The spontaneous appearance of lens precursors (lentoid bodies) from primate and hESCs has been previously reported (<ce:cross-refs refid="bib37 bib54" id="crosrefs0075">Ooto et al., 2003; Zhang et al., 2010</ce:cross-refs>), although the lineage origin and inducing signals remained unexplored in those studies.</ce:para><ce:para id="p0115" view="all">We tested the impact of four developmental signaling pathways on lens placode specification using activators and inhibitors of BMP, FGF, WNT, and Hedgehog signaling. To quantify the induction of lens placode fate, we monitored expression of the lens precursor marker <ce:italic>PITX3</ce:italic> at day 16 of differentiation (<ce:cross-ref refid="app3" id="crosref0675">Figure S6</ce:cross-ref>B). <ce:italic>PITX3</ce:italic> expression was significantly induced in the presence of recombinant BMP4 or upon exposure to the FGF-inhibitory molecule, SU5402 (<ce:cross-ref refid="fig5" id="crosref0680">Figure 5</ce:cross-ref>G). A role for BMPs and FGFs has been previously proposed in developmental studies in the chick (<ce:cross-ref refid="bib46" id="crosref0685">SjÃ¶dal et al., 2007</ce:cross-ref>). Further differentiation revealed strong induction of Î±Î²-crystalline and the formation of mature lens fiber structures by day 57 (<ce:cross-ref refid="fig5" id="crosref0690">Figure 5</ce:cross-ref>H, left panel). The characteristic layering of lens fibers (<ce:cross-ref refid="fig5" id="crosref0695">Figure 5</ce:cross-ref>H, right panel) mimicked the structural properties of developing lens in vivo.</ce:para></ce:section><ce:section id="sec2.8" view="all"><ce:section-title id="sectitle0070">Treatment with SHH at Preplacode Stage Induces Anterior Pituitary Cells</ce:section-title><ce:para id="p0120" view="all">We next explored whether preplacodal cells can be differentiated into anterior pituitary placode and recreate the various pituitary precursors and hormone-producing cell types (<ce:cross-ref refid="fig6" id="crosref0700">Figure 6</ce:cross-ref><ce:float-anchor refid="fig6"/>A). We observed that treatment with agonists for SHH signaling (<ce:cross-ref refid="app3" id="crosref0705">Figure S7</ce:cross-ref>A) at the preplacode stage (days 7-11) induced expression of the oral ectoderm marker <ce:italic>SIX6</ce:italic> and <ce:italic>PITX1</ce:italic> (<ce:cross-ref refid="fig6" id="crosref0710">Figure 6</ce:cross-ref>B), master regulators of pituitary gland development (<ce:cross-ref refid="bib50" id="crosref0715">Tremblay et al., 1998</ce:cross-ref>). Induction of <ce:italic>PITX1</ce:italic> and <ce:italic>SIX6</ce:italic> at transcript and protein levels was dependent on SHH dose (<ce:cross-ref refid="fig6" id="crosref0720">Figures 6</ce:cross-ref>B and 6C). Furthermore, SHH treatment triggered the expression of the definitive pituitary precursor marker LHX3 (<ce:cross-ref refid="fig6" id="crosref0725">Figure 6</ce:cross-ref>D).</ce:para><ce:para id="p0125" view="all">Endocrine cells of the anterior pituitary gland are derived from three main precursors lineages (<ce:cross-ref refid="bib44" id="crosref0730">Scully and Rosenfeld, 2002</ce:cross-ref>). Following PIP + SHH treatment, we observed robust induction of <ce:italic>TBX19</ce:italic> (<ce:cross-ref refid="fig6" id="crosref0735">Figure 6</ce:cross-ref>E), specific to precursors giving rise to ACTH- and MSH-producing cells. Induction of <ce:italic>PIT1</ce:italic> and <ce:italic>GATA2</ce:italic> precursor lineages was less efficient but was increased following treatment with the Î³-secretase inhibitor DAPT (<ce:cross-ref refid="fig6" id="crosref0740">Figures 6</ce:cross-ref>F and 6G). Immunocytochemistry for pituitary hormones showed expression of CGA by 16 days, whereas protein expression of FSH, ACTH, and GH was first observed by days 25-30 of differentiation (<ce:cross-ref refid="fig6" id="crosref0745">Figures 6</ce:cross-ref>H-6K). The induction of ACTH<ce:sup loc="post">+</ce:sup> cells was particularly efficient (<ce:cross-ref refid="fig6" id="crosref0750">Figure 6</ce:cross-ref>J), and in vitro release of ACTH hormone could readily be detected by ELISA (<ce:cross-ref refid="fig6" id="crosref0755">Figure 6</ce:cross-ref>L).</ce:para><ce:para id="p0130" view="all">We next tested whether hESC-derived pituitary cells are capable of in vivo survival and function in mouse and rat xenograft models (<ce:cross-ref refid="fig6" id="crosref0760">Figures 6</ce:cross-ref>M, <ce:cross-ref refid="app3" id="crosref0765">S7</ce:cross-ref>B, and S7C). Subcutaneous injection of GFP-marked, hESC-derived pituitary precursors (day 16 of differentiation) into adult male NOD/SCID mice demonstrated survival of glycoprotein subunit (GSU) and follicle-stimulating hormone (FSH) cells in vivo (<ce:cross-ref refid="app3" id="crosref0775">Figures S7</ce:cross-ref>D and S7E). Longer-term survival studies in nude male rats (n = 8; 4-6 weeks postgrafting) showed significant increases in serum ACTH levels (<ce:cross-ref refid="fig6" id="crosref0780">Figure 6</ce:cross-ref>N) as measured during early morning hours (low point of endogenous ACTH expression during diurnal cycle). We also measured levels of human GH in vivo using an ELISA assay that selectively detects human but not mouse GH (<ce:cross-ref refid="fig6" id="crosref0785">Figure 6</ce:cross-ref>O). Transplantation into rat hosts allowed for repeated blood draws and showed a consistent increase of ACTH and GH levels in grafted as compared to sham injected (Matrigel-only) animals. Finally, histological analysis demonstrated in average 0.46 Â± 0.015 million surviving hNCAM<ce:sup loc="post">+</ce:sup> cells (<ce:cross-ref refid="fig6" id="crosref0790">Figure 6</ce:cross-ref>P) at 6 weeks after transplantation. About 10% of the surviving human cells expressed ACTH (<ce:cross-ref refid="fig6" id="crosref0795">Figure 6</ce:cross-ref>Q) and 6% of the cells were immunoreactive for GH (<ce:cross-ref refid="fig6" id="crosref0800">Figure 6</ce:cross-ref>R). The ability to derive functional hormone-producing pituitary cells from hESCs via modified PIP conditions is particularly intriguing given previous work in mouse ESCs suggesting the need for complex coculture systems to induce pituitary lineages (<ce:cross-ref refid="bib48" id="crosref0805">Suga et al., 2011</ce:cross-ref>). In vivo survival and production of graft-derived ACTH and GH suggest translational potential for patients suffering from genetic, surgical, or radiation induced hypopituitarism (<ce:cross-ref refid="bib49" id="crosref0810">Tabar, 2011</ce:cross-ref>).</ce:para></ce:section></ce:section><ce:section id="sec3" view="all"><ce:section-title id="sectitle0075">Discussion</ce:section-title><ce:section id="sec3.1" view="all"><ce:section-title id="sectitle0080">An Experimental Platform for the Efficient Generation of Human Cranial Placodes In Vitro</ce:section-title><ce:para id="p0135" view="all">The study of human cranial placode development has been challenging due to the lack of a tractable experimental system, the inaccessibility of this transient structure during early human development, and the absence of validated human placode markers. Our data resolve those major challenges and establish a versatile platform for the study of human placode and ectoderm development (<ce:cross-ref refid="fig7" id="crosref0815">Figure 7</ce:cross-ref><ce:float-anchor refid="fig7"/>). Previous studies have observed the emergence of certain placode derivatives such as lens (<ce:cross-refs refid="bib37 bib54" id="crosrefs0080">Ooto et al., 2003; Zhang et al., 2010</ce:cross-refs>) or otic placode-derived cells (<ce:cross-refs refid="bib12 bib38" id="crosrefs0085">Chen et al., 2012; Oshima et al., 2010</ce:cross-refs>). However, the mechanisms of placode induction were not addressed, and no general model of placode specification has emerged from those studies. Very recent studies have shown some promise in directing pluripotent stem cells toward placode fates (<ce:cross-refs refid="bib25 bib33 bib45" id="crosrefs0090">Leung et al., 2013; Mengarelli and Barberi, 2013; Shi et al., 2007</ce:cross-refs>). However, no functional human placode derivatives have been reported under those conditions. In contrast, studies in mouse ESCs have successfully derived functional otic (<ce:cross-ref refid="bib20" id="crosref0820">Koehler et al., 2013</ce:cross-ref>) and pituitary (<ce:cross-ref refid="bib48" id="crosref0825">Suga et al., 2011</ce:cross-ref>) placode derivatives.</ce:para><ce:para id="p0140" view="all">A developmental question of particular interest is the origin of placode cells. The prevalent hypothesis is that placode tissue originates from nonneural ectoderm upon response to inductive signals from the adjacent neural tissue (<ce:cross-ref refid="bib43" id="crosref0830">Schlosser, 2006</ce:cross-ref>). Our data indicate that human placode development similarly originates from nonneural ectoderm based on the result that <ce:italic>TFAP2A</ce:italic> expression precedes the induction of <ce:italic>SIX1</ce:italic>, whereas <ce:italic>TFAP2A</ce:italic> is suppressed during N-SB induction. BMP-based induction of TFAP2A and GATA3 may be critical in establishing nonneural ectoderm lineage competent for placode induction (<ce:cross-ref refid="bib22" id="crosref0835">Kwon et al., 2010</ce:cross-ref>). The ability to block placode induction at the expense of nonneural ectoderm by inhibition of FGF signaling further supports a nonneural ectoderm origin and suggests that endogenous FGF signals may be the neural signal responsible for the placode default in PIP. Our findings further delineate the time point of developmental commitment to placodal fate by day 7, given that treatment of cells at day 7 of differentiation (preplacode) induced a switch between various placode fates but did not affect the ratio of cells of placode versus nonneural ectoderm fate.</ce:para><ce:para id="p0145" view="all">Previous work described FOXG1 and DACH1 as markers of anterior neuroectoderm and neural rosette stage cells during hPSC differentiation (<ce:cross-refs refid="bib10 bib15" id="crosrefs0095">Chambers et al., 2009; Elkabetz et al., 2008</ce:cross-refs>). Our study reports a small percentage of SIX1<ce:sup loc="post">+</ce:sup> cells that emerge spontaneously under N-SB conditions. Therefore, differentiation studies aimed at generating CNS lineages should address whether contaminating placodal tissues are present in hPSC-derived neural cultures. Those spontaneously emerging placodal cells are likely the source of lentoid bodies and other placode derivatives observed in past neural differentiation studies. Our gene expression data define a broad set of placode markers valuable for future studies. For example, OVOL2 has been shown to be expressed in the mouse epiblast and surface ectoderm, and loss of <ce:italic>Ovol2</ce:italic> leads to early embryonic lethality (<ce:cross-ref refid="bib28" id="crosref0840">Mackay et al., 2006</ce:cross-ref>). Here, we define OVOL2 as a human preplacode marker. FOXC1 and ISL1 are additional transcription factors specifically expressed at the preplacode stage. Our data provide a framework for defining transcriptional networks that distinguish cranial placode identity from early CNS, neural crest, and surface ectoderm identity.</ce:para></ce:section><ce:section id="sec3.2" view="all"><ce:section-title id="sectitle0085">Specification toward Functional hESC-Derived Placode Derivatives</ce:section-title><ce:para id="p0150" view="all">The current study defines a transient preplacode population competent to adopt various specific placode identities. The emergence of a preplacodal region has been described during <ce:italic>Xenopus</ce:italic> and zebrafish development (<ce:cross-refs refid="bib4 bib29 bib43" id="crosrefs0100">Bailey et al., 2006; Martin and Groves, 2006; Schlosser, 2006</ce:cross-refs>). Our data indicate that PIP initially yields a PAX6<ce:sup loc="post">+</ce:sup>/SIX1<ce:sup loc="post">+</ce:sup> anterior preplacode population that spontaneously adopts a more posterior, PAX3<ce:sup loc="post">+</ce:sup> ophthalmic trigeminal fate upon further differentiation, likely due to the caudalizing effects of endogenous FGF and WNT signals. Exposure to SHH or suppression of FGF signaling at day 7 of differentiation directs the putative preplacode precursors into anterior pituitary and lens placodes fates. Lens placode has been suggested as the default state during chick placode development with FGF8 being necessary and sufficient to specify olfactory placode fate (<ce:cross-ref refid="bib4" id="crosref0845">Bailey et al., 2006</ce:cross-ref>). Elegant studies in mouse ESCs (<ce:cross-refs refid="bib20 bib48" id="crosrefs0105">Koehler et al., 2013; Suga et al., 2011</ce:cross-refs>) have shown the feasibility of generating hormone-producing pituitary cells and otic sensory neurons respectively using sophisticated 3D culture systems. Our results demonstrate that modified PIP conditions yield human pituitary precursors efficiently without the need for complex 3D culture conditions. Although we observe a bias in generating preferentially TBX19-related pituitary lineages including ACTH-producing cells, all three major precursor lineages (GATA-2, TBX19, and PIT1 lineages, <ce:cross-ref refid="fig6" id="crosref0850">Figure 6</ce:cross-ref>A) could be derived. Therefore, it is likely that further optimization of the protocol will provide selective access to individual pituitary hormone lineages. Our current in vivo studies are limited to a maximum engraftment period of 3 months, subcutaneous injections into the flank of adult murine hosts, and use of animals (both mouse and rat) with normal pituitary function. Future experiments should include longer-term survival studies and an in-depth analysis of graft integration into the hypothalamic-pituitary axis, possibly via orthotopic graft placement into the hypothalamus or the sella. Finally, in vivo hormone function will need to be validated in animal models of pituitary dysfunction.</ce:para><ce:para id="p0155" view="all">We present data on the specification of trigeminal, lens, and anterior pituitary placode lineages. However, preliminary evidence indicates that other placode fates are accessible as well using modified PIP conditions. For example, exposure of preplacode cells to FGF8 enriches for <ce:italic>ASCL1</ce:italic> expression compatible with olfactory placode fate (<ce:cross-ref refid="bib6" id="crosref0855">Balmer and LaMantia, 2005</ce:cross-ref>). Exposure to caudalizing cues such as WNT3A leads to the induction of a population of cells coexpressing SIX1 and SOX10 compatible of otic placode fates. Those conditions, although requiring further optimization, support the notion that PIP represents a universal platform for cranial placode fate specification.</ce:para><ce:para id="p0160" view="all">One of the most immediate applications of PIP-based differentiation is the derivation of trigeminal sensory neurons. Given our recent success in deriving neural-crest-derived nociceptive neurons (<ce:cross-ref refid="bib11" id="crosref0860">Chambers et al., 2012</ce:cross-ref>), it will be intriguing to compare the developmental and functional features of neural crest versus placode-derived nociceptors. Trigeminal neurons are involved in several pain syndromes such as trigeminal nerve palsy, trigeminal neuralgia, and migraine pain (<ce:cross-ref refid="bib27" id="crosref0865">Love and Coakham, 2001</ce:cross-ref>). Therefore, the ability to generate large numbers of trigeminal neurons will be particularly useful for modeling human nociception and for the development of cell-based drug screens in pain research. Another important application will be modeling Herpes simplex encephalitis using human iPSCs (<ce:cross-ref refid="bib23" id="crosref0870">Lafaille et al., 2012</ce:cross-ref>). HSV-1 is a virus that specifically persists in a latent form within the trigeminal ganglia (<ce:cross-ref refid="bib7" id="crosref0875">Barnett et al., 1994</ce:cross-ref>). The ability to derive trigeminal neurons from patient-specific iPSCs should address whether defects in the control of viral latency contributes to Herpes simplex encephalitis. The robust in vivo survival of trigeminal placode precursors raises the possibility for developing future regenerative approaches with the goal of nerve repair following mechanical, radiation, or chemotherapy-induced damage. Finally, the potentially largest impact on regenerative medicine may come from deriving functional hormone-producing cells. Hypopituitarism is a common consequence of congenital defects, head injury, or therapeutic intervention in patients with pituitary tumors or patients receiving radiation therapy (<ce:cross-ref refid="bib49" id="crosref0880">Tabar, 2011</ce:cross-ref>). Although replacement hormones can be given to normalize resting serum levels in patients, the financial, logistic, and medical costs for such lifelong treatments are considerable. Furthermore, hormone replacement therapy does not allow for dynamic release in response to circadian rhythms, or rapid adjustments to physiological changes in the environment or stressful challenges. Therefore, the ability to generate large numbers of functional ACTH- and GH-producing cells launches the possibility of long-term therapeutic cell replacement strategies in pediatric and adult patients for restoring endocrine function.</ce:para></ce:section></ce:section><ce:section id="sec4" role="materials-methods" view="all"><ce:section-title id="sectitle0090">Experimental Procedures</ce:section-title><ce:section id="sec4.1" view="all"><ce:section-title id="sectitle0095">Cell Culture</ce:section-title><ce:para id="p0165" view="all">hESCs (WA-09; passages 35-45), hiPSC lines (iPS-14, iPS-27; passages 20-30), and I6 were maintained at undifferentiated state and differentiated toward CNS lineages using dual-SMAD inhibition protocol described previously. For PIP, Noggin was removed at day 3 of differentiation. In some experiments, BMP-4, Noggin, DKK-1, FGF8, SU5402, Wnt-3a, DAPT, CHIR99021, cyclopamine, Sonic Hedgehog (SHH), and purmorphamine were added as detailed in the <ce:cross-ref refid="app3" id="crosref0885">Supplemental Experimental Procedures</ce:cross-ref>. For differentiation toward trigeminal sensory fate placode clusters were maintained in N2 medium supplemented with ascorbic acid and BDNF. Pituitary fate was induced by exposure to SHH and purmorphamine from day 7 to 11 of PIP followed by treatment with DAPT to promote PIT1<ce:sup loc="post">+</ce:sup> fate.</ce:para></ce:section><ce:section id="sec4.2" view="all"><ce:section-title id="sectitle0100">Cell Characterization</ce:section-title><ce:para id="p0170" view="all">qRT-PCR data were normalized to HPRT and are based on four to six technical replicates from at least three independent experiments. Global gene expression analysis was performed by the MSKCC genomics core according to the specification of the manufacturer (Illumina Human-6 oligonucleotide arrays). Detailed information on the use of primary antibodies for immunocytochemistry and flow analysis and on the electrophysiological analyses is presented in the <ce:cross-ref refid="app3" id="crosref0890">Supplemental Experimental Procedures</ce:cross-ref>.</ce:para></ce:section><ce:section id="sec4.3" view="all"><ce:section-title id="sectitle0105">Animal Studies</ce:section-title><ce:para id="p0175" view="all">Animal studies were done in accordance with protocols approved by our institutional Animal Care and Use Committee and following NIH guidelines. Hormone-producing cells were injected subcutaneously into adult male <ce:italic>NOD-SCID IL2Rgc</ce:italic> mice and eight adult male nude rats. Blood was collected at 4-6 weeks after the transplantation followed by ELISA analysis for determining hormone levels. Chick transplantation studies were performed at HH stage 9-10, and embryos were harvested at HH stage 20. Injections into pons of adult NOD-SCID IL2Rgc mice were performed by stereotactic surgery.</ce:para></ce:section><ce:section id="sec4.4" view="all"><ce:section-title id="sectitle0110">Statistical Analysis</ce:section-title><ce:para id="p0180" view="all">Statistical analysis was performed using GraphPad Prism version 5.0b (GraphPad). All data were derived from at least three independent experiments. Asterisks mark experimental groups that were significantly different from control groups by a two-tailed Students t test, or by ANOVA followed by Dunnett test to compare control against multiple independent treatment groups. Data are presented as mean Â± SEM unless indicated otherwise.</ce:para></ce:section></ce:section></ce:sections><ce:acknowledgment id="ack0010" view="all"><ce:section-title id="sectitle0115">Acknowledgments</ce:section-title><ce:para id="p0185" view="all">This work was supported in part through grants from the Starr Foundation, NINDS grant NS072381, and NYSTEM contract C026447. We are grateful to E. Lai for BF1 antibody, A.S. McNeilly for GSU antibody, R. Vinagolu for FSH antibody, and K. Kawakami for <ce:italic>Eya1::GFP</ce:italic> enhancer element. We also would like to thank H. Ford for advice on SIX1 antibody, M. Hashimi for advice on microarray analysis, M. Tomishima and J. Tchieu for critical review of the manuscript, and M. Bronner for help in designing the chick in vivo transplantation studies.</ce:para></ce:acknowledgment><ce:appendices view="all"><ce:section id="app1" view="all"><ce:section-title id="sectitle0120">Accession Numbers</ce:section-title><ce:para id="p0190" view="all">The GEO accession number for the microarray gene expression data reported in this paper is <ce:inter-ref xlink:href="ncbi-geo:GSE51533" id="intref0020" xlink:type="simple">GSE51533</ce:inter-ref>.</ce:para></ce:section><ce:section id="app2" view="compact-standard"><ce:section-title id="sectitle0125">Supplemental Information</ce:section-title><ce:para id="p0195" view="all">Supplemental Information includes Supplemental Experimental Procedures, seven figures, and two tables and can be found with this article online at <ce:inter-ref xlink:href="doi:10.1016/j.celrep.2013.10.048" id="intref0025" xlink:type="simple">http://dx.doi.org/10.1016/j.celrep.2013.10.048</ce:inter-ref>.</ce:para></ce:section><ce:section id="app3" view="extended"><ce:section-title id="sectitle0130">Supplemental Information</ce:section-title><ce:para id="p0200" view="all"><ce:display><ce:e-component id="mmc1"><ce:label>Document S1. Figures S1-S7 and Supplemental Experimental Procedures</ce:label><ce:link locator="mmc1"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc2"><ce:label>Table S1. PIP Signatures</ce:label><ce:link locator="mmc2"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc3"><ce:label>Table S2. N-SB Signatures</ce:label><ce:link locator="mmc3"/></ce:e-component></ce:display><ce:display><ce:e-component id="mmc4" role="article-plus"><ce:label>Document S2. Article plus Supplemental Information</ce:label><ce:link locator="mmc4"/></ce:e-component></ce:display></ce:para></ce:section></ce:appendices></body><tail view="all"><ce:bibliography id="cebib0010" view="all"><ce:section-title id="sectitle0135">References</ce:section-title><ce:bibliography-sec id="cebibsec0010" view="all"><ce:bib-reference id="bib1"><ce:label>Abdelhak et al., 1997</ce:label><sb:reference id="sref1"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Abdelhak</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Kalatzis</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Heilig</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Compain</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Samson</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Vincent</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Weil</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Cruaud</ce:surname></sb:author><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Sahly</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Leibovici</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>A human homologue of the Drosophila eyes absent gene underlies branchio-oto-renal (BOR) syndrome and identifies a novel gene family</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Genet.</sb:maintitle></sb:title><sb:volume-nr>15</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>157</sb:first-page><sb:last-page>164</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>Ahrens and Schlosser, 2005</ce:label><sb:reference id="sref2"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Ahrens</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlosser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Tissues and signals involved in the induction of placodal Six1 expression in Xenopus laevis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>288</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>40</sb:first-page><sb:last-page>59</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>Arkell and Beddington, 1997</ce:label><sb:reference id="sref3"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Arkell</ce:surname></sb:author><sb:author><ce:given-name>R.S.</ce:given-name><ce:surname>Beddington</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>BMP-7 influences pattern and growth of the developing hindbrain of mouse embryos</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>124</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>12</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib4"><ce:label>Bailey et al., 2006</ce:label><sb:reference id="sref4"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.P.</ce:given-name><ce:surname>Bailey</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bhattacharyya</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bronner-Fraser</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Streit</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Lens specification is the ground state of all sensory placodes, from which FGF promotes olfactory identity</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Cell</sb:maintitle></sb:title><sb:volume-nr>11</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>505</sb:first-page><sb:last-page>517</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>Baker and Bronner-Fraser, 2001</ce:label><sb:reference id="sref5"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.V.</ce:given-name><ce:surname>Baker</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bronner-Fraser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Vertebrate cranial placodes I. Embryonic induction</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>232</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>1</sb:first-page><sb:last-page>61</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib6"><ce:label>Balmer and LaMantia, 2005</ce:label><sb:reference id="sref6"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.W.</ce:given-name><ce:surname>Balmer</ce:surname></sb:author><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>LaMantia</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Noses and neurons: induction, morphogenesis, and neuronal differentiation in the peripheral olfactory pathway</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Developmental dynamics: an official publication of the American Association of Anatomists</sb:maintitle></sb:title><sb:volume-nr>234</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>464</sb:first-page><sb:last-page>481</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib7"><ce:label>Barnett et al., 1994</ce:label><sb:reference id="sref7"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Barnett</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Jacobsen</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Evans</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Cassell</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Perlman</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Herpes simplex encephalitis in the temporal cortex and limbic system after trigeminal nerve inoculation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Infect. Dis.</sb:maintitle></sb:title><sb:volume-nr>169</sb:volume-nr></sb:series><sb:date>1994</sb:date></sb:issue><sb:pages><sb:first-page>782</sb:first-page><sb:last-page>786</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib8"><ce:label>Bernardo et al., 2011</ce:label><sb:reference id="sref8"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Bernardo</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Faial</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Gardner</ce:surname></sb:author><sb:author><ce:given-name>K.K.</ce:given-name><ce:surname>Niakan</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Ortmann</ce:surname></sb:author><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Senner</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Callery</ce:surname></sb:author><sb:author><ce:given-name>M.W.</ce:given-name><ce:surname>Trotter</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hemberger</ce:surname></sb:author><sb:author><ce:given-name>J.C.</ce:given-name><ce:surname>Smith</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>BRACHYURY and CDX2 mediate BMP-induced differentiation of human and mouse pluripotent stem cells into embryonic and extraembryonic lineages</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>144</sb:first-page><sb:last-page>155</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib9"><ce:label>Bhattacharyya and Bronner-Fraser, 2004</ce:label><sb:reference id="sref9"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Bhattacharyya</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bronner-Fraser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Hierarchy of regulatory events in sensory placode development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Curr. Opin. Genet. Dev.</sb:maintitle></sb:title><sb:volume-nr>14</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>520</sb:first-page><sb:last-page>526</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib10"><ce:label>Chambers et al., 2009</ce:label><sb:reference id="sref10"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Chambers</ce:surname></sb:author><sb:author><ce:given-name>C.A.</ce:given-name><ce:surname>Fasano</ce:surname></sb:author><sb:author><ce:given-name>E.P.</ce:given-name><ce:surname>Papapetrou</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Tomishima</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Sadelain</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>27</sb:volume-nr></sb:series><sb:date>2009</sb:date></sb:issue><sb:pages><sb:first-page>275</sb:first-page><sb:last-page>280</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib11"><ce:label>Chambers et al., 2012</ce:label><sb:reference id="sref11"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Chambers</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Qi</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Mica</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>X.J.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Niu</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Bilsland</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Cao</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Stevens</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Whiting</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>30</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>715</sb:first-page><sb:last-page>720</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib12"><ce:label>Chen et al., 2012</ce:label><sb:reference id="sref12"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Jongkamonwiwat</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Abbas</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Eshtan</ce:surname></sb:author><sb:author><ce:given-name>S.L.</ce:given-name><ce:surname>Johnson</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kuhn</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Milo</ce:surname></sb:author><sb:author><ce:given-name>J.K.</ce:given-name><ce:surname>Thurlow</ce:surname></sb:author><sb:author><ce:given-name>P.W.</ce:given-name><ce:surname>Andrews</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Marcotti</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Restoration of auditory evoked responses by human ES-cell-derived otic progenitors</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>490</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>278</sb:first-page><sb:last-page>282</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib13"><ce:label>Colas and Schoenwolf, 2003</ce:label><sb:reference id="sref13"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.F.</ce:given-name><ce:surname>Colas</ce:surname></sb:author><sb:author><ce:given-name>G.C.</ce:given-name><ce:surname>Schoenwolf</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Localization of cartilage linking protein 1 during primary neurulation in the chick embryo</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Brain Res. Dev. Brain Res.</sb:maintitle></sb:title><sb:volume-nr>141</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>141</sb:first-page><sb:last-page>148</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib14"><ce:label>Dennis et al., 2003</ce:label><sb:reference id="sref14"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Dennis</ce:surname></sb:author><sb:author><ce:given-name>B.T.</ce:given-name><ce:surname>Sherman</ce:surname></sb:author><sb:author><ce:given-name>D.A.</ce:given-name><ce:surname>Hosack</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>W.</ce:given-name><ce:surname>Gao</ce:surname></sb:author><sb:author><ce:given-name>H.C.</ce:given-name><ce:surname>Lane</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Lempicki</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>DAVID: database for Annotation, Visualization, and Integrated Discovery</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genome Biology</sb:maintitle></sb:title></sb:series><sb:date>2003</sb:date></sb:issue></sb:host><sb:comment>2003 4:P3 <ce:italic>4</ce:italic>, P3</sb:comment></sb:reference></ce:bib-reference><ce:bib-reference id="bib15"><ce:label>Elkabetz et al., 2008</ce:label><sb:reference id="sref15"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Elkabetz</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Panagiotakos</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Al Shamy</ce:surname></sb:author><sb:author><ce:given-name>N.D.</ce:given-name><ce:surname>Socci</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Tabar</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Human ES cell-derived neural rosettes reveal a functionally distinct early neural stem cell stage</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Genes Dev.</sb:maintitle></sb:title><sb:volume-nr>22</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>152</sb:first-page><sb:last-page>165</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib16"><ce:label>Grigaliunas et al., 2002</ce:label><sb:reference id="sref16"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Grigaliunas</ce:surname></sb:author><sb:author><ce:given-name>R.M.</ce:given-name><ce:surname>Bradley</ce:surname></sb:author><sb:author><ce:given-name>D.K.</ce:given-name><ce:surname>MacCallum</ce:surname></sb:author><sb:author><ce:given-name>C.M.</ce:given-name><ce:surname>Mistretta</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Distinctive neurophysiological properties of embryonic trigeminal and geniculate neurons in culture</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>J. Neurophysiol.</sb:maintitle></sb:title><sb:volume-nr>88</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>2058</sb:first-page><sb:last-page>2074</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib17"><ce:label>Grotewold et al., 2001</ce:label><sb:reference id="sref17"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Grotewold</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Plum</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Dildrop</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Peters</ce:surname></sb:author><sb:author><ce:given-name>U.</ce:given-name><ce:surname>RÃ¼ther</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Bambi is coexpressed with Bmp-4 during mouse embryogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mech. Dev.</sb:maintitle></sb:title><sb:volume-nr>100</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>327</sb:first-page><sb:last-page>330</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib18"><ce:label>Hunter and Rhodes, 2005</ce:label><sb:reference id="sref18"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>C.S.</ce:given-name><ce:surname>Hunter</ce:surname></sb:author><sb:author><ce:given-name>S.J.</ce:given-name><ce:surname>Rhodes</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>LIM-homeodomain genes in mammalian development and human disease</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Biol. Rep.</sb:maintitle></sb:title><sb:volume-nr>32</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>67</sb:first-page><sb:last-page>77</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib19"><ce:label>Ishihara et al., 2008</ce:label><sb:reference id="sref19"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ishihara</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Sato</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Ikeda</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Yajima</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Kawakami</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Multiple evolutionarily conserved enhancers control expression of Eya1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Dyn.</sb:maintitle></sb:title><sb:volume-nr>237</sb:volume-nr></sb:series><sb:date>2008</sb:date></sb:issue><sb:pages><sb:first-page>3142</sb:first-page><sb:last-page>3156</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib20"><ce:label>Koehler et al., 2013</ce:label><sb:reference id="sref20"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.R.</ce:given-name><ce:surname>Koehler</ce:surname></sb:author><sb:author><ce:given-name>A.M.</ce:given-name><ce:surname>Mikosz</ce:surname></sb:author><sb:author><ce:given-name>A.I.</ce:given-name><ce:surname>Molosh</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Patel</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Hashino</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Generation of inner ear sensory epithelia from pluripotent stem cells in 3D culture</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>500</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>217</sb:first-page><sb:last-page>221</sb:last-page></sb:pages><ce:doi>10.1038/nature12298</ce:doi></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib21"><ce:label>Kudoh et al., 2004</ce:label><sb:reference id="sref21"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kudoh</ce:surname></sb:author><sb:author><ce:given-name>M.L.</ce:given-name><ce:surname>Concha</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Houart</ce:surname></sb:author><sb:author><ce:given-name>I.B.</ce:given-name><ce:surname>Dawid</ce:surname></sb:author><sb:author><ce:given-name>S.W.</ce:given-name><ce:surname>Wilson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Combinatorial Fgf and Bmp signalling patterns the gastrula ectoderm into prospective neural and epidermal domains</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>131</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>3581</sb:first-page><sb:last-page>3592</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib22"><ce:label>Kwon et al., 2010</ce:label><sb:reference id="sref22"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.J.</ce:given-name><ce:surname>Kwon</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Bhat</ce:surname></sb:author><sb:author><ce:given-name>E.M.</ce:given-name><ce:surname>Sweet</ce:surname></sb:author><sb:author><ce:given-name>R.A.</ce:given-name><ce:surname>Cornell</ce:surname></sb:author><sb:author><ce:given-name>B.B.</ce:given-name><ce:surname>Riley</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Identification of early requirements for preplacodal ectoderm and sensory organ development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>PLoS Genet.</sb:maintitle></sb:title><sb:volume-nr>6</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>e1001133</sb:first-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib23"><ce:label>Lafaille et al., 2012</ce:label><sb:reference id="sref23"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>F.G.</ce:given-name><ce:surname>Lafaille</ce:surname></sb:author><sb:author><ce:given-name>I.M.</ce:given-name><ce:surname>Pessach</ce:surname></sb:author><sb:author><ce:given-name>S.-Y.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Ciancanelli</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Herman</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Abhyankar</ce:surname></sb:author><sb:author><ce:given-name>S.-Y.</ce:given-name><ce:surname>Ying</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Keros</ce:surname></sb:author><sb:author><ce:given-name>P.A.</ce:given-name><ce:surname>Goldstein</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Mostoslavsky</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Impaired intrinsic IFN-Î±/Î² immunity to HSV-1 in human iPSC-derived UNC-93B- and TLR3-deficient central nervous system cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>491</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>769</sb:first-page><sb:last-page>773</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib24"><ce:label>Lee et al., 2007</ce:label><sb:reference id="sref24"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kim</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Elkabetz</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Al Shamy</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Panagiotakos</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Barberi</ce:surname></sb:author><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Tabar</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Isolation and directed differentiation of neural crest stem cells derived from human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>25</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>1468</sb:first-page><sb:last-page>1475</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib25"><ce:label>Leung et al., 2013</ce:label><sb:reference id="sref25"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.W.</ce:given-name><ce:surname>Leung</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Kent Morest</ce:surname></sb:author><sb:author><ce:given-name>J.Y.</ce:given-name><ce:surname>Li</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential BMP signaling controls formation and differentiation of multipotent preplacodal ectoderm progenitors from human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>379</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>208</sb:first-page><sb:last-page>220</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib26"><ce:label>Litsiou et al., 2005</ce:label><sb:reference id="sref26"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Litsiou</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Hanson</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Streit</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>A balance of FGF, BMP and WNT signalling positions the future placode territory in the head</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>132</sb:volume-nr></sb:series><sb:date>2005</sb:date></sb:issue><sb:pages><sb:first-page>4051</sb:first-page><sb:last-page>4062</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib27"><ce:label>Love and Coakham, 2001</ce:label><sb:reference id="sref27"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Love</ce:surname></sb:author><sb:author><ce:given-name>H.B.</ce:given-name><ce:surname>Coakham</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Trigeminal neuralgia: pathology and pathogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Brain</sb:maintitle></sb:title><sb:volume-nr>124</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>2347</sb:first-page><sb:last-page>2360</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib28"><ce:label>Mackay et al., 2006</ce:label><sb:reference id="sref28"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.R.</ce:given-name><ce:surname>Mackay</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Hu</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>RhÃ©aume</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Dai</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The mouse Ovol2 gene is required for cranial neural tube development</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>291</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>38</sb:first-page><sb:last-page>52</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib29"><ce:label>Martin and Groves, 2006</ce:label><sb:reference id="sref29"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Martin</ce:surname></sb:author><sb:author><ce:given-name>A.K.</ce:given-name><ce:surname>Groves</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Competence of cranial ectoderm to respond to Fgf signaling suggests a two-step model of otic placode induction</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>133</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>877</sb:first-page><sb:last-page>887</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib30"><ce:label>McCabe et al., 2004</ce:label><sb:reference id="sref30"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.L.</ce:given-name><ce:surname>McCabe</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Manzo</ce:surname></sb:author><sb:author><ce:given-name>L.S.</ce:given-name><ce:surname>Gammill</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bronner-Fraser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Discovery of genes implicated in placode formation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>274</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>462</sb:first-page><sb:last-page>477</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib31"><ce:label>McCauley and Bronner-Fraser, 2002</ce:label><sb:reference id="sref31"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>D.W.</ce:given-name><ce:surname>McCauley</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bronner-Fraser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Conservation of Pax gene expression in ectodermal placodes of the lamprey</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Gene</sb:maintitle></sb:title><sb:volume-nr>287</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>129</sb:first-page><sb:last-page>139</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib32"><ce:label>Menendez et al., 2011</ce:label><sb:reference id="sref32"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Menendez</ce:surname></sb:author><sb:author><ce:given-name>T.A.</ce:given-name><ce:surname>Yatskievych</ce:surname></sb:author><sb:author><ce:given-name>P.B.</ce:given-name><ce:surname>Antin</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Dalton</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripotent stem cells to multipotent neural crest cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>108</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>19240</sb:first-page><sb:last-page>19245</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib33"><ce:label>Mengarelli and Barberi, 2013</ce:label><sb:reference id="sref33"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>I.</ce:given-name><ce:surname>Mengarelli</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Barberi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Derivation of multiple cranial tissues and isolation of lens epithelium-like cells from human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Stem Cells Transl. Med.</sb:maintitle></sb:title><sb:volume-nr>2</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>94</sb:first-page><sb:last-page>106</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib34"><ce:label>Metcalfe et al., 1990</ce:label><sb:reference id="sref34"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>W.K.</ce:given-name><ce:surname>Metcalfe</ce:surname></sb:author><sb:author><ce:given-name>P.Z.</ce:given-name><ce:surname>Myers</ce:surname></sb:author><sb:author><ce:given-name>B.</ce:given-name><ce:surname>Trevarrow</ce:surname></sb:author><sb:author><ce:given-name>M.B.</ce:given-name><ce:surname>Bass</ce:surname></sb:author><sb:author><ce:given-name>C.B.</ce:given-name><ce:surname>Kimmel</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Primary neurons that express the L2/HNK-1 carbohydrate during early development in the zebrafish</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>110</sb:volume-nr></sb:series><sb:date>1990</sb:date></sb:issue><sb:pages><sb:first-page>491</sb:first-page><sb:last-page>504</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib35"><ce:label>Mica et al., 2013</ce:label><sb:reference id="sref35"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Mica</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lee</ce:surname></sb:author><sb:author><ce:given-name>S.M.</ce:given-name><ce:surname>Chambers</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Tomishima</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Studer</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Modeling neural crest induction, melanocyte specification, and disease-related pigmentation defects in hESCs and patient-specific iPSCs</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Rep.</sb:maintitle></sb:title><sb:volume-nr>3</sb:volume-nr></sb:series><sb:date>2013</sb:date></sb:issue><sb:pages><sb:first-page>1140</sb:first-page><sb:last-page>1152</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib36"><ce:label>O'Rahilly, 1987</ce:label><sb:reference id="sref36"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.M.F.</ce:given-name><ce:surname>O'Rahilly</ce:surname></sb:author></sb:authors></sb:contribution><sb:host><sb:book><sb:book-series><sb:series><sb:title><sb:maintitle>Developmental Stages in Human Embryos</sb:maintitle></sb:title><sb:volume-nr>Vol. 637</sb:volume-nr></sb:series></sb:book-series><sb:date>1987</sb:date><sb:publisher><sb:name>Carnegie Institution of Washington</sb:name><sb:location>Washington, DC</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib37"><ce:label>Ooto et al., 2003</ce:label><sb:reference id="sref37"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Ooto</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Haruta</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Honda</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Kawasaki</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Sasai</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Takahashi</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Induction of the differentiation of lentoids from primate embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Invest. Ophthalmol. Vis. Sci.</sb:maintitle></sb:title><sb:volume-nr>44</sb:volume-nr></sb:series><sb:date>2003</sb:date></sb:issue><sb:pages><sb:first-page>2689</sb:first-page><sb:last-page>2693</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib38"><ce:label>Oshima et al., 2010</ce:label><sb:reference id="sref38"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Oshima</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Shin</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Diensthuber</ce:surname></sb:author><sb:author><ce:given-name>A.W.</ce:given-name><ce:surname>Peng</ce:surname></sb:author><sb:author><ce:given-name>A.J.</ce:given-name><ce:surname>Ricci</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Heller</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Mechanosensitive hair cell-like cells from embryonic and induced pluripotent stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell</sb:maintitle></sb:title><sb:volume-nr>141</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>704</sb:first-page><sb:last-page>716</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib39"><ce:label>Pieper et al., 2012</ce:label><sb:reference id="sref39"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Pieper</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Ahrens</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Rink</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Peter</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlosser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential distribution of competence for panplacodal and neural crest induction to non-neural and neural ectoderm</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>139</sb:volume-nr></sb:series><sb:date>2012</sb:date></sb:issue><sb:pages><sb:first-page>1175</sb:first-page><sb:last-page>1187</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib40"><ce:label>Reubinoff et al., 2001</ce:label><sb:reference id="sref40"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>B.E.</ce:given-name><ce:surname>Reubinoff</ce:surname></sb:author><sb:author><ce:given-name>P.</ce:given-name><ce:surname>Itsykson</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Turetsky</ce:surname></sb:author><sb:author><ce:given-name>M.F.</ce:given-name><ce:surname>Pera</ce:surname></sb:author><sb:author><ce:given-name>E.</ce:given-name><ce:surname>Reinhartz</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Itzik</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Ben-Hur</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Neural progenitors from human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>1134</sb:first-page><sb:last-page>1140</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib41"><ce:label>Ruf et al., 2004</ce:label><sb:reference id="sref41"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.G.</ce:given-name><ce:surname>Ruf</ce:surname></sb:author><sb:author><ce:given-name>P.X.</ce:given-name><ce:surname>Xu</ce:surname></sb:author><sb:author><ce:given-name>D.</ce:given-name><ce:surname>Silvius</ce:surname></sb:author><sb:author><ce:given-name>E.A.</ce:given-name><ce:surname>Otto</ce:surname></sb:author><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Beekmann</ce:surname></sb:author><sb:author><ce:given-name>U.T.</ce:given-name><ce:surname>Muerb</ce:surname></sb:author><sb:author><ce:given-name>S.</ce:given-name><ce:surname>Kumar</ce:surname></sb:author><sb:author><ce:given-name>T.J.</ce:given-name><ce:surname>Neuhaus</ce:surname></sb:author><sb:author><ce:given-name>M.J.</ce:given-name><ce:surname>Kemper</ce:surname></sb:author><sb:author><ce:given-name>R.M.</ce:given-name><ce:surname>Raymond</ce:surname><ce:suffix>Jr.</ce:suffix></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Proc. Natl. Acad. Sci. USA</sb:maintitle></sb:title><sb:volume-nr>101</sb:volume-nr></sb:series><sb:date>2004</sb:date></sb:issue><sb:pages><sb:first-page>8090</sb:first-page><sb:last-page>8095</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib42"><ce:label>Sasaki and Hogan, 1993</ce:label><sb:reference id="sref42"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Sasaki</ce:surname></sb:author><sb:author><ce:given-name>B.L.</ce:given-name><ce:surname>Hogan</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Differential expression of multiple fork head related genes during gastrulation and axial pattern formation in the mouse embryo</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>118</sb:volume-nr></sb:series><sb:date>1993</sb:date></sb:issue><sb:pages><sb:first-page>47</sb:first-page><sb:last-page>59</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib43"><ce:label>Schlosser, 2006</ce:label><sb:reference id="sref43"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Schlosser</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Induction and specification of cranial placodes</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Biol.</sb:maintitle></sb:title><sb:volume-nr>294</sb:volume-nr></sb:series><sb:date>2006</sb:date></sb:issue><sb:pages><sb:first-page>303</sb:first-page><sb:last-page>351</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib44"><ce:label>Scully and Rosenfeld, 2002</ce:label><sb:reference id="sref44"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>K.M.</ce:given-name><ce:surname>Scully</ce:surname></sb:author><sb:author><ce:given-name>M.G.</ce:given-name><ce:surname>Rosenfeld</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Pituitary development: regulatory codes in mammalian organogenesis</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Science</sb:maintitle></sb:title><sb:volume-nr>295</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>2231</sb:first-page><sb:last-page>2235</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib45"><ce:label>Shi et al., 2007</ce:label><sb:reference id="sref45"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>F.</ce:given-name><ce:surname>Shi</ce:surname></sb:author><sb:author><ce:given-name>C.E.</ce:given-name><ce:surname>Corrales</ce:surname></sb:author><sb:author><ce:given-name>M.C.</ce:given-name><ce:surname>Liberman</ce:surname></sb:author><sb:author><ce:given-name>A.S.</ce:given-name><ce:surname>Edge</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>BMP4 induction of sensory neurons from human embryonic stem cells and reinnervation of sensory epithelium</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Eur. J. Neurosci.</sb:maintitle></sb:title><sb:volume-nr>26</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>3016</sb:first-page><sb:last-page>3023</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib46"><ce:label>SjÃ¶dal et al., 2007</ce:label><sb:reference id="sref46"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.</ce:given-name><ce:surname>SjÃ¶dal</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Edlund</ce:surname></sb:author><sb:author><ce:given-name>L.</ce:given-name><ce:surname>Gunhaga</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Time of exposure to BMP signals plays a key role in the specification of the olfactory and lens placodes ex vivo</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Dev. Cell</sb:maintitle></sb:title><sb:volume-nr>13</sb:volume-nr></sb:series><sb:date>2007</sb:date></sb:issue><sb:pages><sb:first-page>141</sb:first-page><sb:last-page>149</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib47"><ce:label>Stark et al., 1997</ce:label><sb:reference id="sref47"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>M.R.</ce:given-name><ce:surname>Stark</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Sechrist</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Bronner-Fraser</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Marcelle</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Neural tube-ectoderm interactions are required for trigeminal placode formation</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>124</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>4287</sb:first-page><sb:last-page>4295</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib48"><ce:label>Suga et al., 2011</ce:label><sb:reference id="sref48"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Suga</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Kadoshima</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Minaguchi</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Ohgushi</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Soen</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Nakano</ce:surname></sb:author><sb:author><ce:given-name>N.</ce:given-name><ce:surname>Takata</ce:surname></sb:author><sb:author><ce:given-name>T.</ce:given-name><ce:surname>Wataya</ce:surname></sb:author><sb:author><ce:given-name>K.</ce:given-name><ce:surname>Muguruma</ce:surname></sb:author><sb:author><ce:given-name>H.</ce:given-name><ce:surname>Miyoshi</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Self-formation of functional adenohypophysis in three-dimensional culture</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nature</sb:maintitle></sb:title><sb:volume-nr>480</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>57</sb:first-page><sb:last-page>62</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib49"><ce:label>Tabar, 2011</ce:label><sb:reference id="sref49"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>V.</ce:given-name><ce:surname>Tabar</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Making a pituitary gland in a dish</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>9</sb:volume-nr></sb:series><sb:date>2011</sb:date></sb:issue><sb:pages><sb:first-page>490</sb:first-page><sb:last-page>491</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib50"><ce:label>Tremblay et al., 1998</ce:label><sb:reference id="sref50"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J.J.</ce:given-name><ce:surname>Tremblay</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>LanctÃ´t</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Drouin</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Mol. Endocrinol.</sb:maintitle></sb:title><sb:volume-nr>12</sb:volume-nr></sb:series><sb:date>1998</sb:date></sb:issue><sb:pages><sb:first-page>428</sb:first-page><sb:last-page>441</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib51"><ce:label>Wilson et al., 1997</ce:label><sb:reference id="sref51"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>P.A.</ce:given-name><ce:surname>Wilson</ce:surname></sb:author><sb:author><ce:given-name>G.</ce:given-name><ce:surname>Lagna</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Suzuki</ce:surname></sb:author><sb:author><ce:given-name>A.</ce:given-name><ce:surname>Hemmati-Brivanlou</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Concentration-dependent patterning of the Xenopus ectoderm by BMP4 and its signal transducer Smad1</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Development</sb:maintitle></sb:title><sb:volume-nr>124</sb:volume-nr></sb:series><sb:date>1997</sb:date></sb:issue><sb:pages><sb:first-page>3177</sb:first-page><sb:last-page>3184</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib52"><ce:label>Xu et al., 2002</ce:label><sb:reference id="sref52"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>R.H.</ce:given-name><ce:surname>Xu</ce:surname></sb:author><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>D.S.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>R.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>G.C.</ce:given-name><ce:surname>Addicks</ce:surname></sb:author><sb:author><ce:given-name>C.</ce:given-name><ce:surname>Glennon</ce:surname></sb:author><sb:author><ce:given-name>T.P.</ce:given-name><ce:surname>Zwaka</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Thomson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>BMP4 initiates human embryonic stem cell differentiation to trophoblast</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>20</sb:volume-nr></sb:series><sb:date>2002</sb:date></sb:issue><sb:pages><sb:first-page>1261</sb:first-page><sb:last-page>1264</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib53"><ce:label>Zhang et al., 2001</ce:label><sb:reference id="sref53"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>S.C.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Wernig</ce:surname></sb:author><sb:author><ce:given-name>I.D.</ce:given-name><ce:surname>Duncan</ce:surname></sb:author><sb:author><ce:given-name>O.</ce:given-name><ce:surname>BrÃ¼stle</ce:surname></sb:author><sb:author><ce:given-name>J.A.</ce:given-name><ce:surname>Thomson</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>In vitro differentiation of transplantable neural precursors from human embryonic stem cells</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Nat. Biotechnol.</sb:maintitle></sb:title><sb:volume-nr>19</sb:volume-nr></sb:series><sb:date>2001</sb:date></sb:issue><sb:pages><sb:first-page>1129</sb:first-page><sb:last-page>1133</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib54"><ce:label>Zhang et al., 2010</ce:label><sb:reference id="sref54"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>X.</ce:given-name><ce:surname>Zhang</ce:surname></sb:author><sb:author><ce:given-name>C.T.</ce:given-name><ce:surname>Huang</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Chen</ce:surname></sb:author><sb:author><ce:given-name>M.T.</ce:given-name><ce:surname>Pankratz</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Xi</ce:surname></sb:author><sb:author><ce:given-name>J.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>Y.</ce:given-name><ce:surname>Yang</ce:surname></sb:author><sb:author><ce:given-name>T.M.</ce:given-name><ce:surname>Lavaute</ce:surname></sb:author><sb:author><ce:given-name>X.J.</ce:given-name><ce:surname>Li</ce:surname></sb:author><sb:author><ce:given-name>M.</ce:given-name><ce:surname>Ayala</ce:surname></sb:author><sb:et-al/></sb:authors><sb:title><sb:maintitle>Pax6 is a human neuroectoderm cell fate determinant</sb:maintitle></sb:title></sb:contribution><sb:host><sb:issue><sb:series><sb:title><sb:maintitle>Cell Stem Cell</sb:maintitle></sb:title><sb:volume-nr>7</sb:volume-nr></sb:series><sb:date>2010</sb:date></sb:issue><sb:pages><sb:first-page>90</sb:first-page><sb:last-page>100</sb:last-page></sb:pages></sb:host></sb:reference></ce:bib-reference></ce:bibliography-sec></ce:bibliography></tail></article></xocs:serial-item></xocs:doc>
